Processing 00000000.tx.1: Comparison of pathways controlling toxicity in the eye and brain in Drosophila models of human neurodegenerative diseases Srimoyee Ghosh and Mel B. 

Phrase: "Comparison of pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "toxicity in the eye"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1262036:ocular toxicity [Injury or Poisoning]
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "brain in Drosophila"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "models of human neurodegenerative diseases Srimoyee Ghosh"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   757   C0683033:disease model [Intellectual Product]
   757   C0684309:Disease model [Experimental Model of Disease]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0086418:Human [Human]
   748   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "Mel B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0809907:Mel B [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.2: Feany* Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 77 Louis Pasteur Avenue, Room 630, Boston, MA 02115, USA Received April 26, 2004; 

Phrase: "Feany"

Phrase: "* Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Brigham and Women's Hospital"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C0043210:Women [Population Group]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "and"

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "77 Louis Pasteur Avenue,"

Phrase: "Room 630,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1547703:Room [Spatial Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115,"

Phrase: "USA Received April 26,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.3: Accepted July 6, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Most human neurodegenerative diseases have a number of common features, including adult onset, progressive degeneration of selected neuronal populations and formation of abnormal protein aggregates. 

Phrase: "Accepted July 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Most human neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "a number of common features,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "adult onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836537:Adult onset [Finding]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "progressive degeneration of selected neuronal populations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]
   748   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "formation of abnormal protein aggregates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597295:protein formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.4: Although these shared characteristics raise the possibility of conserved pathogenic mechanisms, the diverse clinical and pathological features of each disorder indicate significant differences. 

Phrase: "Although"

Phrase: "these shared characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "raise"

Phrase: "the possibility of conserved pathogenic mechanisms,"

Phrase: "the diverse clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological features of each disorder"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1521970:Feature [Qualitative Concept]
   726   C1706388:Feature [Conceptual Entity]
   726   C2346469:Feature [Qualitative Concept]
   726   C2348519:Feature [Qualitative Concept]

Phrase: "indicate"

Phrase: "significant differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.5: As a number of human neurodegenerative diseases have now been modeled in Drosophila, and genetic modifiers identified, we have been able to perform a genetic comparison of pathways controlling toxicity in these models. 

Phrase: "As a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of human neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "modeled in Drosophila,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013138:Drosophila [Eukaryote]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   756   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "genetic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "been"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "a genetic comparison of pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "toxicity in these models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.6: By directly comparing modifiers isolated in the models of polyglutamine diseases and in a Drosophila model of tauopathy, we find a final common pathway of cell death involving apoptosis. 

Phrase: "By directly comparing modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205349:Modifier [Qualitative Concept]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "isolated in the models of polyglutamine diseases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   757   C0683033:disease models [Intellectual Product]
   757   C0684309:disease models [Experimental Model of Disease]
   748   C0012634:Diseases [Disease or Syndrome]
   748   C0205409:Isolated [Functional Concept]
   748   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   748   C1548221:Isolated [Idea or Concept]
   748   C3161035:Models [Intellectual Product]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and in a Drosophila model of tauopathy,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0013138:Drosophila [Eukaryote]
   748   C0949664:Tauopathy [Disease or Syndrome]
   748   C1028876:Drosophila [Fungus]
   748   C1504613:Drosophila [Eukaryote]
   748   C1515981:And [Idea or Concept]
   748   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a final common pathway of cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.7: Among the polyglutamine diseases, protein folding and histone acetylation are common key mediators. 

Phrase: "Among the polyglutamine diseases,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "histone acetylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156200:Histone Acetylation [Molecular Function]
   861   C0001038:Acetylation [Molecular Function]
   861   C1521754:Acetylation [Molecular Function]

Phrase: "are"

Phrase: "common key mediators."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   793 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: In addition, two novel modifiers suggest shared pathways of toxicity among all the disorders. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "two novel modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205349:Modifier [Qualitative Concept]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "shared pathways of toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "among all"

Phrase: "the disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.9: Cell-type specificity is a salient feature of all neurodegenerative diseases; 

Phrase: "Cell-type specificity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   901   C0007634:Cell Type [Cell]
           Cell
   901   C0449475:cell type [Intellectual Product]
   827   C0037791:Specificity [Quantitative Concept]
   827   C0332307:Type [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1511884:Specificity [Quantitative Concept]
   827   C1547052:*Type [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205369:Specific [Qualitative Concept]
   755 E C1552740:specific [Intellectual Product]

Phrase: "is"

Phrase: "a salient feature of all neurodegenerative diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.10: however, most work to date in the Drosophila models have been performed in the retina. 

Phrase: "however,"

Phrase: "most work to date"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "in the Drosophila models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "performed in the retina."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C0884358:Performed [Functional Concept]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.11: Therefore, we determined whether similar pathways of toxicity operate in neurons of the Drosophila brain. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "similar pathways of toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "operate in neurons of the Drosophila brain."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0013138:Drosophila [Eukaryote]
   748   C0027882:Neurons [Cell]
   748   C1028876:Drosophila [Fungus]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1504613:Drosophila [Eukaryote]
   748   C3242339:operate [Functional Concept]
Processing 00000000.tx.12: Many, but not all, retinal modifiers also modify toxicity in postmitotic neurons in the brain. 

Phrase: "Many,"

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all,"

Phrase: "retinal modifiers also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205349:Modifier [Qualitative Concept]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "toxicity in postmitotic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.13: Analysis of polyglutamine toxicity in the adult brain facilitated the identification of nicotinamide (vitamin B3), a vitamin with histone deacetylase inhibiting activity, as a potent suppressor of polyglutamine toxicity. 

Phrase: "Analysis of polyglutamine toxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the adult brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "facilitated"

Phrase: "the identification of nicotinamide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "(vitamin B3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "a vitamin with histone deacetylase"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0042839:a vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   797 E C2825076:Vitamin A [Pharmacologic Substance]
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "a potent suppressor of polyglutamine toxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1710252:Suppressor [Manufactured Object]
   753   C2954564:Suppressor [Pharmacologic Substance]
Processing 00000000.tx.14: These findings outline common pathways of neurotoxicity, demonstrate disease- and cell-type specific pathways and identify a common vitamin as a potential therapy in polyglutamine disorders.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "outline"

Phrase: "common pathways of neurotoxicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "demonstrate"

Phrase: "disease-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "cell-type specific pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "identify"

Phrase: "a common vitamin as a potential therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0042839:Vitamin A [Organic Chemical,Pharmacologic Substance,Vitamin]
   774   C0302837:therapy vitamin [Pharmacologic Substance]
   774   C1533658:vitamin therapy [Therapeutic or Preventive Procedure]
   774   C2825076:Vitamin A [Pharmacologic Substance]
   748   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "in polyglutamine disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and disorders like Huntington's disease that are caused by polyglutamine expansions have a number of common features: late adult onset, progressive degeneration of vulnerable subsets of neurons and formation of abnormal protein aggregates. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Neurodegenerative diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "disorders like Huntington's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0012634:disease/disorder [Disease or Syndrome]
           Disorders

Phrase: "that"

Phrase: "are"

Phrase: "caused by polyglutamine expansions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "have"

Phrase: "a number of common features"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: ":"

Phrase: "late adult onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1836537:Adult onset [Finding]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "progressive degeneration of vulnerable subsets of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "formation of abnormal protein aggregates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597295:protein formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.16: These aggregates may be extracellular, as in the amyloid plaque of Alzheimer's disease, or they may occur in various intracellular compartments. 

Phrase: "These aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "extracellular,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521119:Extracellular [Cell Component]

Phrase: "as in the amyloid plaque of Alzheimer's disease,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0333463:amyloid plaque [Acquired Abnormality]
           plaque
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C2936349:Plaque, Amyloid [Acquired Abnormality]
   767   C0002726:amyloid disease [Disease or Syndrome]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011389:Plaque [Disease or Syndrome]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0332461:Plaque [Finding]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "they"

Phrase: "may"

Phrase: "occur in various intracellular compartments."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.17: Huntington's disease and related polyglutamine disorders typically have intranuclear inclusions. 

Phrase: "Huntington's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "related polyglutamine disorders typically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0012634:Disorders [Disease or Syndrome]

Phrase: "have"

Phrase: "intranuclear inclusions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1366904:Intranuclear Inclusions [Cell Component]
   827   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.18: Cytoplasmic inclusions involving the cell soma include the neurofibrillary tangle of Alzheimer's disease and the Lewy body of Parkinson's disease. 

Phrase: "Cytoplasmic inclusions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205708:Cytoplasmic Inclusions [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0521449:Cytoplasmic [Body Location or Region]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the cell soma"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0599444:Cell soma [Cell Component]
           soma
  1000   C2752549:cell soma [Cell Component]
   861   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   805 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   768 E C2986476:Somatic [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the neurofibrillary tangle of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085400:Neurofibrillary tangle [Acquired Abnormality]
   790   C3543859:neurofibrillary tangle [Cell Component]

Phrase: "and"

Phrase: "the Lewy body of Parkinson's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0030567:Lewy Body Parkinson Disease [Disease or Syndrome]
   820   C0752347:Lewy Body Disease [Disease or Syndrome]
   790   C0085200:Lewy Body [Cell Component]
   753   C0242821:body [Human]
   753   C0460148:Body [Anatomical Structure]
   753   C1268086:Body [Anatomical Structure]
Processing 00000000.tx.19: In addition, most disorders show at least some degree of neuritic inclusion pathology. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "most disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]

Phrase: "show at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1547282:Show [Intellectual Product]

Phrase: "some degree of neuritic inclusion pathology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.20: These similarities imply that neurodegenerative diseases may share important common pathogenic features. 

Phrase: "These similarities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2348205:Similarity [Qualitative Concept]

Phrase: "imply"

Phrase: "that neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "may"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "important common pathogenic features."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1521970:Feature [Qualitative Concept]
   779   C1706388:Feature [Conceptual Entity]
   779   C2346469:Feature [Qualitative Concept]
   779   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.21: In particular, the presence of abnormal protein aggregates in all of these disorders has supported the idea that neurodegenerative disorders may be diseases of toxic proteins that aggregate abnormally and thereby cause cell dysfunction and death (1). 

Phrase: "In particular,"

Phrase: "the presence of abnormal protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0033672:Abnormal presence of protein [Finding]
           Protein, abnormal presence
   862   C0332198:presence of abnormal [Functional Concept]
           abnormal presence
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "aggregates in all of these disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012634:Disorders [Disease or Syndrome]
   753   C0205418:Aggregate [Qualitative Concept]

Phrase: "has"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "diseases of toxic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012634:Diseases [Disease or Syndrome]

Phrase: "that"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "abnormally"

Phrase: "and"

Phrase: "thereby"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: The idea that abnormal protein folding and aggregation are key abnormalities in neurodegenerative diseases has also gained support from initial genetic modifier screens performed in Drosophila. 

Phrase: "The idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that abnormal protein folding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0162847:protein folding [Molecular Function]
   827   C0185026:Folding [Therapeutic or Preventive Procedure]
   734   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "are"

Phrase: "key abnormalities in neurodegenerative diseases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "has"

Phrase: "also gained support from initial genetic modifier screens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0183683:Support [Medical Device]
   744   C1521721:Support [Conceptual Entity]

Phrase: "performed in Drosophila."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0013138:Drosophila [Eukaryote]
   790   C0884358:Performed [Functional Concept]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.23: The first polyglutamine disease modeled in flies was spinocerebellar ataxia type 3 (SCA3) (2). 

Phrase: "The first polyglutamine disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "modeled in flies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0012578:Flies [Eukaryote]
   756 E C1704307:Fly [Eukaryote]
   756   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "spinocerebellar ataxia type 3 (SCA3)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: Subsequently, heat shock proteins were shown to play a critical role in ataxin 3 toxicity. 

Phrase: "Subsequently,"

Phrase: "heat shock proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in ataxin 3 toxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.25: Overexpression of human heat shock protein 70 (Hsp70) substantially ameliorated ataxin 3 retinal toxicity in the Drosophila model of SCA3, whereas the expression of a dominant negative form of Drosophila heat shock protein 40 enhanced retinal toxicity (3). 

Phrase: "Overexpression of human heat shock protein 70 (Hsp70) substantially ameliorated ataxin 3 retinal toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   749   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in the Drosophila model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "of SCA3,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "whereas"

Phrase: "the expression of a dominant negative form"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C1554102:Formal Expression [Idea or Concept]

Phrase: "of Drosophila heat shock protein 40 enhanced retinal toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   812   C0877104:retinal toxicity [Anatomical Abnormality]
   793   C0040539:toxicity [Qualitative Concept]
   793   C0600688:Toxicity [Injury or Poisoning]
   721 E C1407029:Toxic [Qualitative Concept]
   700 E C0032346:Poison [Hazardous or Poisonous Substance]
   700 E C1548769:Poison [Intellectual Product]
   700 E C1550590:poison [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: Similarly, Kazemi-Esfarjani and Benzer (4) performed a forward genetic screen in a separate model of polyglutamine toxicity based on the expression of a stretch of 127 glutamines attached to a histidine tag (Q127) and found the suppression of polyglutamine toxicity in the retina by the expression of the heat shock protein Hdj1 and the treicorepeat protein Tpr-2 that contains a DNAJ domain. 

Phrase: "Similarly,"

Phrase: "Kazemi-Esfarjani"

Phrase: "and"

Phrase: "Benzer"

Phrase: "(4"

Phrase: ")"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a forward genetic screen in a separate model of polyglutamine toxicity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0813145:Genetic screen [Diagnostic Procedure]
   754   C0026343:Model, Genetic [Intellectual Product]
   738   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   738   C0220908:screen [Health Care Activity]
   738   C0314603:Genetic [Functional Concept]
   738   C1305399:screen [Functional Concept]
   738   C1705053:Screen [Medical Device]

Phrase: "based on the expression of a stretch of 127 glutamines"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0600080:stretch [Therapeutic or Preventive Procedure]
   739   C1527178:Based [Functional Concept]
   739   C1705938:Based [Idea or Concept]
   706 E C0002055:base [Inorganic Chemical]
   706   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "attached to a histidine tag (Q127"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C0231441:Attached [Finding]
   753   C1710492:TAG [Gene or Genome]
   719 E C1314972:ATTACH [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "the suppression of polyglutamine toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "by the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the heat shock protein Hdj1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1415791:HDJ1 [Gene or Genome]
   756   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the treicorepeat protein Tpr-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1098484:TPR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1420877:TPR [Gene or Genome]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a DNAJ domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.27: These studies likely have relevance to vertebrates because overexpression of human Hsp70 ameliorated toxicity in mouse model of spinocerebellar ataxia type 1 (SCA1) (5). 

Phrase: "These studies likely"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "relevance to vertebrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347946:Relevance [Qualitative Concept]

Phrase: "because"

Phrase: "overexpression of human Hsp70 ameliorated toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of spinocerebellar ataxia type 1 (SCA1)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.28: Expression of human Hsp70 has also been reported to suppress neurotoxicity in a Drosophila model of Parkinson's disease (6). 

Phrase: "Expression of human Hsp70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "neurotoxicity in a Drosophila model of Parkinson's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.29: Despite persuasive arguments for common underlying disease mechanisms, clinical and pathological analyses reveal striking differences among neurodegenerative disorders. 

Phrase: "Despite persuasive arguments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680226:arguments [Social Behavior]
   827 E C1704769:Argument [Conceptual Entity]

Phrase: "for common underlying disease mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "striking differences among neurodegenerative disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.30: For example, Alzheimer's disease is characterized by cognitive dysfunction and degeneration of cortical neurons. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "characterized by cognitive dysfunction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0338656:Cognitive dysfunction [Mental or Behavioral Dysfunction]
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C1516691:Cognitive [Functional Concept]
   770   C1880022:Characterized [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "degeneration of cortical neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   819   C3554171:Cortical degeneration [Finding]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.31: Pathologically, extracellular amyloid plaques and intracellular neurofibrillary tangles are seen. 

Phrase: "Pathologically,"

Phrase: "extracellular amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "intracellular neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   901   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   867 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "seen."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]
Processing 00000000.tx.32: In contrast, patients with Huntington's disease have abnormal movements (chorea) and selective degeneration of striatal neurons accompanied by intranuclear inclusion formation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "patients with Huntington's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "have"

Phrase: "abnormal movements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013384:Abnormal Movements [Disease or Syndrome]
  1000   C0558189:Abnormal movement [Finding]
   861   C0026649:Movement [Organism Function]

Phrase: "(chorea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008489:Chorea [Disease or Syndrome]

Phrase: ")"

Phrase: "and"

Phrase: "selective degeneration of striatal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "accompanied by intranuclear inclusion formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1366904:Intranuclear inclusion [Cell Component]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1512693:Inclusion [Qualitative Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.33: Clearly, the cellular pathways controlling cell death in these disorders must be distinct at least to some degree. 

Phrase: "Clearly,"

Phrase: "the cellular pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "cell death in these disorders"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "must"

Phrase: "be"

Phrase: "distinct at least"

Phrase: "to some degree."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0441889:Degree [Qualitative Concept]
  1000   C0449286:Degree [Quantitative Concept]
  1000   C0542560:Degree [Intellectual Product]
  1000   C1561545:degree [Quantitative Concept]
  1000   C2348088:Degree [Quantitative Concept]
Processing 00000000.tx.34: In fact, the polyglutamine disorders provide a particularly salient example of the differences that must occur even among neurodegenerative disorders with similar underlying pathogenic mechanisms. 

Phrase: "In fact,"

Phrase: "the polyglutamine disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a particularly salient example of the differences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707959:Example [Conceptual Entity]

Phrase: "that"

Phrase: "must"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "even among neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   833   C1522560:Neurodegenerative Disorders [Functional Concept]
   770   C0012634:Disorders [Disease or Syndrome]

Phrase: "with similar underlying pathogenic mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.35: Polyglutamine disorders are dominantly inherited neurodegenerative diseases that result from the expansion of a CAG repeat within the coding region of the disease gene, producing an abnormally long polyglutamine tract. 

Phrase: "Polyglutamine disorders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "are"

Phrase: "dominantly"

Phrase: "inherited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439660:Inherited [Functional Concept]

Phrase: "neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "that"

Phrase: "result from the expansion of a CAG repeat"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205341:Repeat [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   744   C2825142:Result [Finding]

Phrase: "within the coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0079941:Coding Region [Gene or Genome]
   861   C0009219:Coding [Occupational Activity]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the disease gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   972   C1416989:MAL gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "producing"

Phrase: "an abnormally long polyglutamine tract."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1185740:Tract [Body Part, Organ, or Organ Component]
Processing 00000000.tx.36: To date, nine neurodegenerative disorders caused by polyglutamine expansions have been identified: Huntington's disease, dentatorubropallidoluysian atrophy, spinobulbar muscular atrophy and several SCAs (7). 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "nine neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   901   C1522560:Neurodegenerative Disorders [Functional Concept]
   827   C0012634:Disorders [Disease or Syndrome]

Phrase: "caused by polyglutamine expansions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ":"

Phrase: "Huntington's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "dentatorubropallidoluysian atrophy,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0751781:Dentatorubral-Pallidoluysian Atrophy [Disease or Syndrome]
   861   C0333641:Atrophy [Pathologic Function]
   789 E C0151514:Atrophic [Disease or Syndrome]

Phrase: "spinobulbar muscular atrophy"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0752353:Atrophy, Muscular, Spinobulbar [Disease or Syndrome]
           Spinobulbar Atrophy
   901   C0026846:Muscular Atrophy [Disease or Syndrome]
   827   C0026845:Muscular [Tissue]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0442025:Muscular [Spatial Concept]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C1995013:Muscles [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "several SCAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0149575:SCA [Body Part, Organ, or Organ Component]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.37: Each of these disorders is characterized by selective neuronal loss in specific regions of the brain. 

Phrase: "Each of these disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012634:Disorders [Disease or Syndrome]
   770   C1457900:Each [Quantitative Concept]

Phrase: "is"

Phrase: "characterized by selective neuronal loss"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1517945:Loss [Quantitative Concept]
   760   C1880022:Characterized [Activity]

Phrase: "in specific regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.38: The predilection of Huntington's disease for the caudate and the putamen has been mentioned earlier. 

Phrase: "The predilection of Huntington's disease"

Phrase: "for the caudate"

Phrase: "and"

Phrase: "the putamen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034169:Putamen [Body Part, Organ, or Organ Component]
  1000   C1281335:Putamen [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "been"

Phrase: "mentioned"

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.39: In two of the diseases modeled in the current work, SCA3 and SCA1, there is some overlap in the affected areas, but SCA3 is distinguished from SCA1 by the relative preponderance of pathology in the basal ganglia. 

Phrase: "In two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "of the diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "modeled in the current work,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0043227:Work [Occupational Activity]
   760   C0521116:Current [Temporal Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   726   C3161035:Model [Intellectual Product]

Phrase: "SCA3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "and"

Phrase: "SCA1,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "there"

Phrase: "is"

Phrase: "some overlap in the affected areas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185027:overlap [Therapeutic or Preventive Procedure]
   753   C1948020:Overlap [Conceptual Entity]

Phrase: "but"

Phrase: "SCA3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "is"

Phrase: "distinguished from SCA1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   882   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   790   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   790   C0441729:Type 1 [Classification]
   753   C0004134:Ataxia [Sign or Symptom]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "by the relative preponderance"

Phrase: "of pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "in the basal ganglia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004781:Basal Ganglia [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
Processing 00000000.tx.40: In contrast, SCA1 tends to show severe cerebellar cortical and marked spinal cord involvement, including the cholinergic anterior horn cells (8). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "SCA1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "tends"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "severe cerebellar cortical"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0001613:Cortical [Body Part, Organ, or Organ Component]
   827   C0007776:Cortical [Body Part, Organ, or Organ Component]
   827   C0022655:Cortical [Body Part, Organ, or Organ Component]
   771 E C0234875:bark [Organism Attribute]
   771 E C2700441:Bark [Plant]
   743 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   743 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "marked spinal cord involvement,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0748903:spinal cord involvement [Disease or Syndrome]
   875   C0444534:Spinal involvement [Body Location or Region]
   812   C1314939:Involvement [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the cholinergic anterior horn cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0003154:Anterior Horn Cells [Cell]
   902   C1183202:Cholinergic cells [Cell]
   861   C0228590:Anterior horn [Body Part, Organ, or Organ Component]
   827   C1275629:horn cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0019939:Horn [Body Part, Organ, or Organ Component]
   812   C0205094:Anterior [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.41: Thus, protein context must be critical in determining the clinical and pathological differences evident in the various polyglutamine disorders. 

Phrase: "Thus,"

Phrase: "protein context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "must"

Phrase: "be"

Phrase: "critical in determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1511545:Critical [Qualitative Concept]

Phrase: "the clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathological differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "evident in the various polyglutamine disorders."
Processing 00000000.tx.42: As a number of neurodegenerative diseases have now been modeled in Drosophila, and genetic modifiers identified, we can use a comparative genetic approach to identify common and distinct pathways among these disorders. 

Phrase: "As a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "been"

Phrase: "modeled in Drosophila,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013138:Drosophila [Eukaryote]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   756   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "genetic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "we"

Phrase: "can"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "a comparative genetic approach to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449445:Approach [Spatial Concept]

Phrase: "identify"

Phrase: "common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205214:Common [Quantitative Concept]
  1000   C1522138:Common [Functional Concept]
  1000   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "distinct pathways among these disorders."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.43: In addition to the effects of the heat shock proteins, previous modifier analyses have identified components of the ubiquitin/proteasome system as key mediators of polyglutamine toxicity (9,10). 

Phrase: "In addition to the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of the heat shock proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]

Phrase: "previous modifier analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "identified components of the ubiquitin/proteasome system"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "as key mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of polyglutamine toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.44: A number of RNA binding proteins have been implicated in SCA1 pathogenesis (9). 

Phrase: "A number of RNA binding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in SCA1 pathogenesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   778   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   778   C0441729:Type 1 [Classification]
   748   C0004134:Ataxia [Sign or Symptom]
   748   C0332307:Type [Qualitative Concept]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.45: The control of histone acetylation is important in a fly model of Huntington's disease (11), and has also been implicated in mouse models of Huntington's disease (12,13). 

Phrase: "The control of histone acetylation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "is"

Phrase: "important in a fly model of Huntington's disease"

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]

Phrase: "models of Huntington's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0020179:Huntington Disease [Disease or Syndrome]
   833   C2919056:Huntington's Disease [Functional Concept]
   819   C0683033:disease model [Intellectual Product]
   819   C0684309:Disease model [Experimental Model of Disease]
   770   C0012634:Disease [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.46: In contrast, a modifier screen in a Drosophila model of tauopathy implicated phosphorylation as a major determinant of tau neurotoxicity, but did not identify components of the protein folding or degradation machinery (14). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a modifier screen in a Drosophila model of tauopathy implicated phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220908:screen [Health Care Activity]
   738   C1305399:screen [Functional Concept]
   738   C1705053:Screen [Medical Device]

Phrase: "as a major determinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521761:Determinant [Functional Concept]

Phrase: "of tau neurotoxicity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "identify"

Phrase: "components of the protein folding"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "or"

Phrase: "degradation machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337076:machinery [Manufactured Object]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.47: Specificity for particular subsets of neurons is a common feature in the polyglutamine diseases modeled in Drosophila, but thus far genetic modifiers have been predominantly derived from genetic screens or candidate testing in the retina. 

Phrase: "Specificity for particular subsets of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "a common feature in the polyglutamine diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "modeled in Drosophila,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0013138:Drosophila [Eukaryote]
   790   C1028876:Drosophila [Fungus]
   790   C1504613:Drosophila [Eukaryote]
   756   C3161035:Model [Intellectual Product]

Phrase: "but"

Phrase: "thus far genetic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C0205349:Modifier [Qualitative Concept]
   779   C1514623:Modifier [Conceptual Entity]
   779   C1516451:Modifier [Chemical Viewed Functionally]
   779   C3542952:Modifier [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "predominantly"

Phrase: "derived from genetic screens"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   799   C0813145:Genetic screen [Diagnostic Procedure]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "or"

Phrase: "candidate testing in the retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0039593:Testing [Functional Concept]
   760   C0392366:testing [Intellectual Product]
Processing 00000000.tx.48: Therefore, we determined whether the modifiers could also affect defined subsets of neurons in the brain of Drosophila. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "the modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "could"

Phrase: "also"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "defined subsets of neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515021:Subset [Classification]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.49: We have thus developed robust models for studying toxicity in postmitotic neurons of the brain. 

Phrase: "We"

Phrase: "have"

Phrase: "thus"

Phrase: "developed"

Phrase: "robust models for studying toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0026336:Study models [Intellectual Product,Research Device]
   760   C3161035:Models [Intellectual Product]

Phrase: "in postmitotic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.50: In general, we find that common pathways mediate toxicity in polyglutamine diseases both in the retina and in the brain. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that common pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "toxicity in polyglutamine diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "both in the retina"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C0238767:Both [Spatial Concept]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
   770   C1706086:Both [Qualitative Concept]

Phrase: "and in the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.51: These pathways are generally distinct from those operating in tauopathy. 

Phrase: "These pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "generally distinct from those operating"

Phrase: "in tauopathy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]
Processing 00000000.tx.52: However, we also identify modifiers that are specific for particular cell types in the nervous system and for individual disease models as well as two modifiers that show activity in all the models tested.  

Phrase: "However,"

Phrase: "we also"

Phrase: "identify"

Phrase: "modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "specific for particular cell types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205369:Specific [Qualitative Concept]
   760   C1552740:specific [Intellectual Product]

Phrase: "in the nervous system"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0027763:Nervous System [Body System]
  1000   C0422837:NERVOUS SYSTEM [Finding]
  1000   C1269560:Nervous system [Body System]
   944 E C0205494:Neurologic [Qualitative Concept]
   907 E C0027855:Neurology [Biomedical Occupation or Discipline]
   888 E C2707261:Neurological [Clinical Attribute]
   861   C0027769:Nervous [Sign or Symptom]
   861   C0449913:System [Functional Concept]
   861   C0599851:Nervous [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
   745 E C0027740:Nerve [Tissue]
   745 E C0027757:NERVE [Tissue]
   745 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and for individual disease models"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0683033:disease models [Intellectual Product]
   806   C0684309:disease models [Experimental Model of Disease]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0027361:Individual [Population Group]
   760   C0237401:Individual [Human]
   760   C1515981:And [Idea or Concept]
   760   C3161035:Models [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "as well as"

Phrase: "two modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "activity in all"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.53: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  To determine whether common pathways control cell death in the Drosophila models of human neurodegenerative diseases, we tested modifiers previously described in polyglutamine diseases (3,4,9,10,11) and in tauopathy (14) in models of SCA3 (2), SCA1 (15) and a polyglutamine disease model consisting of an expanded polyglutamine tract of 127 residues attached to a histidine tag (Q127) (4). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "common pathways control cell death in the Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007587:Cell Death [Cell Function]
   744   C0011065:Death [Organism Function]
   744   C1306577:Death, NOS [Finding]

Phrase: "models of human neurodegenerative diseases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "modifiers previously"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "described in polyglutamine diseases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:Diseases [Disease or Syndrome]
   770   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   770   C1552738:described [Idea or Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "9,"

Phrase: "10,"

Phrase: "11"

Phrase: ")"

Phrase: "and in tauopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0949664:Tauopathy [Disease or Syndrome]
   790   C1515981:And [Idea or Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "in models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "of SCA3"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441731:Type 3 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "SCA1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "a polyglutamine disease model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683033:disease model [Intellectual Product]
   901   C0684309:Disease model [Experimental Model of Disease]
   827   C3161035:Model [Intellectual Product]

Phrase: "consisting of an expanded polyglutamine tract of 127 residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205229:expanded [Spatial Concept]
   742   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   742   C1185740:Tract [Body Part, Organ, or Organ Component]
   708   C0332529:CONSIST [Qualitative Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "attached to a histidine tag (Q127"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C0231441:Attached [Finding]
   753   C1710492:TAG [Gene or Genome]
   719 E C1314972:ATTACH [Intellectual Product]

Phrase: ")"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.54: Previously described polyglutamine modifiers included transgenes capable of overexpressing human Hsp70 and a dominant negative form of Drosophila heat shock cognate 4 (Hsc4DN) (3), a large number of modifiers recovered in the forward genetic screen to identify modifiers of SCA1 toxicity (9) and transgenes capable of overexpressing Hdj1 and Tpr-2 (4). 

Phrase: "Previously described polyglutamine modifiers included transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0282641:Transgenes [Gene or Genome]

Phrase: "capable of overexpressing human Hsp70"

Phrase: "and"

Phrase: "a dominant negative form of Drosophila heat shock cognate 4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   739   C0205160:Negative [Qualitative Concept]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1513916:Negative [Finding]
   739   C1522492:Form [Functional Concept]
   739   C1527180:Dominant [Functional Concept]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "(Hsc4DN"

Phrase: ")"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a large number of modifiers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "recovered in the forward genetic screen to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0813145:Genetic screen [Diagnostic Procedure]
   748   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   748   C0220908:screen [Health Care Activity]
   748   C0314603:Genetic [Functional Concept]
   748   C0439780:Forward [Spatial Concept]
   748   C0521108:recovered [Qualitative Concept]
   748   C1305399:screen [Functional Concept]
   748   C1705053:Screen [Medical Device]
   714 E C2004454:recover [Organism Function]

Phrase: "identify"

Phrase: "modifiers of SCA1 toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0205349:Modifier [Qualitative Concept]
   714   C1514623:Modifier [Conceptual Entity]
   714   C1516451:Modifier [Chemical Viewed Functionally]
   714   C3542952:Modifier [Intellectual Product]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgenes [Gene or Genome]

Phrase: "capable of overexpressing Hdj1"

Phrase: "and"

Phrase: "Tpr-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1098484:TPR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420877:TPR [Gene or Genome]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.55: A complete list of polyglutamine modifiers tested is included in Materials and Methods. 

Phrase: "A complete list of polyglutamine modifiers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0745732:List [Conceptual Entity]
   753   C3272378:LIST [Intellectual Product]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "is"

Phrase: "included in Materials"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332257:included [Functional Concept]
   790   C0520510:Materials [Substance]
   790   C3538986:INCLUDED [Gene or Genome]
   756 E C1552866:include [Idea or Concept]
   756 E C2700399:Include [Activity]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.56: In addition, drugs capable of inhibiting histone deacetylase, including sodium butyrate and nicotinamide (vitamin B3), were also used. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "capable of inhibiting histone deacetylase,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "sodium butyrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   861   C0006521:butyrate [Lipid]
   861   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   861   C0220802:butyrate [Lipid]
   861   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "nicotinamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(vitamin B3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "also"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.57: The modifiers that produced unequivocal effects in at least one of the models, but did not themselves cause a rough eye in trans to GMR-GAL4, are presented in Table 1 and were pursued further. 

Phrase: "The modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "produced"

Phrase: "unequivocal effects in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "at least one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "of the models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "but"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "themselves"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a rough eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0015392:Eye [Body Part, Organ, or Organ Component]
   861   C1280202:Eye [Body Part, Organ, or Organ Component]
   805 E C0029144:optic [Occupation or Discipline]
   805 E C0042789:Ocular [Organism Function]
   805 E C1299003:Ocular [Spatial Concept]
   768 E C0014236:Ophthalmia [Disease or Syndrome]
   768 E C0700042:Oculus [Body Location or Region]

Phrase: "in trans to GMR-GAL4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2826298:TRANS [Idea or Concept]

Phrase: "are"

Phrase: "presented in Table 1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "pursued"

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.58: Two modifiers, UAS-Tpr (4) and EP(2)2417 (9) caused a rough eye in trans to GMR-GAL4 and were not examined further. 

Phrase: "Two modifiers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "UAS-Tpr (4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1098484:TPR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420877:TPR [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2417"

Phrase: "(9"

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rough eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0015392:Eye [Body Part, Organ, or Organ Component]
   861   C1280202:Eye [Body Part, Organ, or Organ Component]
   805 E C0029144:optic [Occupation or Discipline]
   805 E C0042789:Ocular [Organism Function]
   805 E C1299003:Ocular [Spatial Concept]
   768 E C0014236:Ophthalmia [Disease or Syndrome]
   768 E C0700042:Oculus [Body Location or Region]

Phrase: "in trans to GMR-GAL4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2826298:TRANS [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.59: We also tested the entire group of modifiers recently identified in the laboratory as enhancers or suppressors of the rough eye produced by the expression of human tau in the fly retina (14). 

Phrase: "We also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the entire group of modifiers recently"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "identified in the laboratory"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3244292:laboratory [Functional Concept]

Phrase: "as enhancers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "suppressors of the rough eye"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1710252:Suppressor [Manufactured Object]
   726   C2954564:Suppressor [Pharmacologic Substance]

Phrase: "produced by the expression of human tau"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0086418:Human [Human]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1720655:Tau [Intellectual Product]
   748   C1947974:Tau [Research Activity]

Phrase: "in the fly retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.60: The entire list of these modifiers is given in Materials and Methods. 

Phrase: "The entire list of these modifiers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0745732:List [Conceptual Entity]
   753   C3272378:LIST [Intellectual Product]

Phrase: "is"

Phrase: "given in Materials"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0520510:Materials [Substance]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.61: None of these modifiers produced a significant rough eye in trans to GMR-GAL4. 

Phrase: "None of these modifiers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "produced"

Phrase: "a significant rough eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0015392:Eye [Body Part, Organ, or Organ Component]
   827   C1280202:Eye [Body Part, Organ, or Organ Component]
   771 E C0029144:optic [Occupation or Discipline]
   771 E C0042789:Ocular [Organism Function]
   771 E C1299003:Ocular [Spatial Concept]
   734 E C0014236:Ophthalmia [Disease or Syndrome]
   734 E C0700042:Oculus [Body Location or Region]

Phrase: "in trans to GMR-GAL4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2826298:TRANS [Idea or Concept]
Processing 00000000.tx.62: Only modifiers that produced a clear enhancement or suppression in at least one polyglutamine model were pursued further. 

Phrase: "Only modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "produced"

Phrase: "a clear enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   861   C2349975:Enhancement [Activity]

Phrase: "or"

Phrase: "suppression in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0221103:Suppression [Pathologic Function]
   833   C0301625:Suppression [Organism Function]
   833   C0439181:% suppression [Quantitative Concept]
   833   C0728721:suppression [Mental Process]

Phrase: "at least one polyglutamine model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "were"

Phrase: "pursued"

Phrase: "further."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]
Processing 00000000.tx.63: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.64: Effects of genetic modifiers on retinal and brain toxicity  Modifiers of retinal toxicity The modifiers that proved generally most effective in the models tested were the heat shock proteins. 

Phrase: "Effects of genetic modifiers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   786   C0681891:effect modifier [Functional Concept]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on retinal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035298:Retinal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "brain toxicity  Modifiers of retinal toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   719   C0205349:Modifier [Qualitative Concept]
   719   C1514623:Modifier [Conceptual Entity]
   719   C1516451:Modifier [Chemical Viewed Functionally]
   719   C3542952:Modifier [Intellectual Product]

Phrase: "The modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "proved"

Phrase: "generally most effective in the models"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "the heat shock proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]
Processing 00000000.tx.65: Although overexpression of the heat shock proteins Hsp70 or Hdj1 did not suppress tau retinal toxicity (14), these transgenes provided the most general and robust modification of polyglutamine toxicity (Table 1, Fig.1). 

Phrase: "Although"

Phrase: "overexpression of the heat shock proteins Hsp70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1514559:Overexpression [Genetic Function]
           Protein Overexpression

Phrase: "or"

Phrase: "Hdj1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415791:HDJ1 [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "tau retinal toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0877104:retinal toxicity [Anatomical Abnormality]
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "these transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282641:Transgenes [Gene or Genome]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the most general"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205246:General [Spatial Concept]
   861   C1553889:General [Idea or Concept]

Phrase: "and"

Phrase: "robust modification of polyglutamine toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.66: When an expanded form of ataxin 3 (UAS-SCA3-78) was expressed in the retina (driver: GMR-GAL4), flies showed moderately rough and depigmented eyes at eclosion (Fig.1A). 

Phrase: "When"

Phrase: "an expanded form of ataxin 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(UAS-SCA3-78"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   827   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0441731:Type 3 [Classification]
   799   C0004134:Ataxia [Sign or Symptom]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   727 E C0234366:Ataxic [Sign or Symptom]

Phrase: ")"

Phrase: "was"

Phrase: "expressed in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "GMR-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "moderately rough"

Phrase: "and"

Phrase: "depigmented eyes at eclosion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0015392:Eyes [Body Part, Organ, or Organ Component]
   737 E C1280202:Eye [Body Part, Organ, or Organ Component]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.67: Similarly, expression of an expanded version of ataxin 1 (UAS-SCA1-82) or Q127 (UAS-Q127) also produced roughened and depigmented eyes (Fig.1E and I). 

Phrase: "Similarly,"

Phrase: "expression of an expanded version of ataxin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(UAS-SCA1-82"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   827   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0441729:Type 1 [Classification]
   799   C0004134:Ataxia [Sign or Symptom]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   727 E C0234366:Ataxic [Sign or Symptom]

Phrase: ")"

Phrase: "or"

Phrase: "Q127"

Phrase: "(UAS-Q127"

Phrase: ")"

Phrase: "also"

Phrase: "produced"

Phrase: "roughened"

Phrase: "and"

Phrase: "depigmented eyes"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   861   C0015392:Eyes [Body Part, Organ, or Organ Component]
   827 E C1280202:Eye [Body Part, Organ, or Organ Component]
   789 E C0029144:optic [Occupation or Discipline]
   789 E C0042789:Ocular [Organism Function]
   789 E C1299003:Ocular [Spatial Concept]
   761 E C0014236:Ophthalmia [Disease or Syndrome]
   761 E C0700042:Oculus [Body Location or Region]

Phrase: "(Fig.1E"

Phrase: "and"

Phrase: "I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.68: Overexpression of either human Hsp70 or Drosophila Hdj1 suppressed the retinal toxicity in each of the polyglutamine models (Table 1, Fig.1B, F and J). 

Phrase: "Overexpression of either human Hsp70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "or"

Phrase: "Drosophila Hdj1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415791:HDJ1 [Gene or Genome]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the retinal toxicity in each of the polyglutamine models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0877104:retinal toxicity [Anatomical Abnormality]
   742   C0040539:toxicity [Qualitative Concept]
   742   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "J"

Phrase: ")."
Processing 00000000.tx.69: View larger version (101K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(101K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.70: Effects of modifiers on retinal toxicity of mutant ataxin 3 (AD), mutant ataxin 1 (EH) or Q127 (IL) (driver: GMR-GAL4). 

Phrase: "Effects of modifiers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   824   C0681891:effect modifier [Functional Concept]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on retinal toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0877104:retinal toxicity [Anatomical Abnormality]
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "of mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "mutant ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "(EH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520135:EH [Geographic Area]

Phrase: "or"

Phrase: "Q127"

Phrase: "(IL) (driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684312:driver [Population Group]
   861   C1556026:Driver [Professional or Occupational Group]
   861   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "GMR-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.71: Expression of human Hsp70 (B) or the baculovirus antiapoptotic protein p35 (C) suppresses ataxin 3 toxicity. 

Phrase: "Expression of human Hsp70 ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "the baculovirus antiapoptotic protein p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3539715:p35 [Gene or Genome]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "ataxin 3 toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C1538301:ATAXIN 3 [Gene or Genome]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.72: The EP element EP(2)2510 (D) enhances ataxin 3 toxicity. 

Phrase: "The EP element EP(2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: ")"

Phrase: "2510"

Phrase: "("

Phrase: "D)"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "ataxin 3 toxicity."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C1538301:ATAXIN 3 [Gene or Genome]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.73: Expression of human Hsp70 (F) or p35 (G) suppresses ataxin 1 toxicity. 

Phrase: "Expression of human Hsp70 (F)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "ataxin 1 toxicity."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.74: The EP element EP(2)2510 (H) enhances ataxin 1 toxicity. 

Phrase: "The EP element EP(2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: ")"

Phrase: "2510"

Phrase: "(H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "ataxin 1 toxicity."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0040539:toxicity [Qualitative Concept]
   827   C0600688:Toxicity [Injury or Poisoning]
   755 E C1407029:Toxic [Qualitative Concept]
   734 E C0032346:Poison [Hazardous or Poisonous Substance]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]
   734 E C1548769:Poison [Intellectual Product]
   734 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.75: Expression of Drosophila HDJ1 (J) suppresses Q127 toxicity, but expression of p35 (K) is ineffective. 

Phrase: "Expression of Drosophila HDJ1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(J)"

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "Q127 toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "but"

Phrase: "expression of p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "is"

Phrase: "ineffective."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.76: The EP element EP(2)2510 (L) enhances Q127 toxicity.  

Phrase: "The EP element EP(2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: ")"

Phrase: "2510"

Phrase: "(L)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Q127 toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.77: Expression of antiapoptotic proteins also produced a modification in most of the models. 

Phrase: "Expression of antiapoptotic proteins also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "produced"

Phrase: "a modification in most of the models."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.78: The baculovirus protein p35 and the Drosophila DIAP1 homolog thread suppressed the retinal toxicity of expanded ataxin 3 (Table 1, Fig.1C) (2), expanded ataxin 1 (Table 1, Fig.1G) and tau (Table 1) (14,16). 

Phrase: "The baculovirus protein p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539715:p35 [Gene or Genome]

Phrase: "and"

Phrase: "the Drosophila DIAP1 homolog thread"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1710394:Thread [Manufactured Object]
   812   C1882475:Thread [Intellectual Product]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "the retinal toxicity of expanded ataxin 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0877104:retinal toxicity [Anatomical Abnormality]
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1C"

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "expanded ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1G"

Phrase: ")"

Phrase: "and"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "(14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.79: However, no suppression of retinal toxicity in flies expressing the Q127 protein was observed (Table 1, Fig.1K). 

Phrase: "However,"

Phrase: "no suppression of retinal toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "in flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]

Phrase: "expressing"

Phrase: "the Q127 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1K"

Phrase: ")."
Processing 00000000.tx.80: Crosses of flies expressing Q127 with flies expressing p35 or thread were repeated at 17C to minimize endogenous toxicity of Q127 in an attempt to uncover modification by the antiapoptotic proteins. 

Phrase: "Crosses of flies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C2828360:Cross [Conceptual Entity]

Phrase: "expressing"

Phrase: "Q127 with flies"

Phrase: "expressing"

Phrase: "p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "or"

Phrase: "thread"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710394:Thread [Manufactured Object]
  1000   C1882475:Thread [Intellectual Product]

Phrase: "were"

Phrase: "repeated at 17C to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205341:Repeated [Functional Concept]
   737 E C1547730:Repeat [Temporal Concept]
   737 E C1705914:Repeat [Conceptual Entity]

Phrase: "minimize"

Phrase: "endogenous toxicity of Q127"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in an attempt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"

Phrase: "uncover"

Phrase: "modification by the antiapoptotic proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0033666:Protein Modification [Molecular Function]
   781   C2263112:protein modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.81: No modification was observed with the more modest toxicity of Q127 seen at the lower temperature (Supplementary Material). 

Phrase: "No modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "was"

Phrase: "observed with the more modest toxicity of Q127"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0040539:toxicity [Qualitative Concept]
   744   C0600688:Toxicity [Injury or Poisoning]
   744   C1441672:Observed [Functional Concept]

Phrase: "seen at the lower temperature"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: ")."
Processing 00000000.tx.82: One goal of this work was to determine whether there is genetic evidence for a common pathway controlling neurodegeneration in the Drosophila models of human neurodegenerative diseases. 

Phrase: "One goal of this work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018017:Goal [Intellectual Product]
   760   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "is"

Phrase: "genetic evidence for a common pathway controlling neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332120:Evidence [Functional Concept]

Phrase: "in the Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "models of human neurodegenerative diseases."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.83: Two modifiers were active in all the models tested. 

Phrase: "Two modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "active in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205177:Active [Functional Concept]

Phrase: "the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.84: The EP element insertion EP(2)2510 enhanced the retinal toxicity in all the models (Table 1, Fig.1D, H and L). 

Phrase: "The EP element insertion EP(2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0021107:Insertion [Therapeutic or Preventive Procedure]
   804   C0441587:Insertion [Health Care Activity]
   804   C1512796:Insertion [Genetic Function]
   804   C1705248:Element [Conceptual Entity]
   804   C1883719:Insertion [Functional Concept]

Phrase: ")"

Phrase: "2510"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the retinal toxicity in all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0877104:retinal toxicity [Anatomical Abnormality]
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig.1D, H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "L)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.85: The EP(2)2510 insertion is in the first exon of the novel gene CG7231 in the inactivating orientation. 

Phrase: "The EP(2"

Phrase: ")"

Phrase: "2510 insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021107:Insertion [Therapeutic or Preventive Procedure]
   861   C0441587:Insertion [Health Care Activity]
   861   C1512796:Insertion [Genetic Function]
   861   C1883719:Insertion [Functional Concept]

Phrase: "is in the first exon of the novel gene CG7231"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0314622:Is gene [Gene or Genome]
   739   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0017337:Gene [Gene or Genome]
   739   C0205314:Novel [Temporal Concept]
   739   C0205435:First [Quantitative Concept]
   739   C0679622:novel [Intellectual Product]
   739   C1279901:First [Qualitative Concept]

Phrase: "in the inactivating orientation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.86: Precise excision of this element reverts the modification in all the models tested, suggesting that the EP element is responsible for the phenotype. 

Phrase: "Precise excision of this element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "reverts"

Phrase: "the modification in all"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the EP element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013879:Element [Element, Ion, or Isotope]
   861   C1705248:Element [Conceptual Entity]

Phrase: "is"

Phrase: "responsible for the phenotype."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]
Processing 00000000.tx.87: A second insertion in CG7231, KG04307, showed similar enhancement of tau toxicity, supporting the identification of CG7231 as the modifying locus. 

Phrase: "A second insertion in CG7231,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021107:Insertion [Therapeutic or Preventive Procedure]
   760   C0441587:Insertion [Health Care Activity]
   760   C1512796:Insertion [Genetic Function]
   760   C1883719:Insertion [Functional Concept]

Phrase: "KG04307,"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar enhancement of tau toxicity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the identification of CG7231"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "as the modifying locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.88: Overexpression of the Drosophila homolog of ataxin 2 also enhanced the retinal pathology in all of the models (Table 1). 

Phrase: "Overexpression of the Drosophila homolog of ataxin 2 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514559:Overexpression [Genetic Function]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the retinal pathology in all of the models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0030664:Pathology [Biomedical Occupation or Discipline]
   744   C0205469:pathology [Functional Concept]
   744   C0677042:pathology [Pathologic Function]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.89: Modifiers of neurotoxicity in the brain Because efficient utilization of Drosophila as a genetic tool requires simple, robust and rapid tests for phenotypic modification, most genetic analyses in the Drosophila models of human neurodegenerative diseases have focused on the retina. 

Phrase: "Modifiers of neurotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0205349:Modifier [Qualitative Concept]
   756   C1514623:Modifier [Conceptual Entity]
   756   C1516451:Modifier [Chemical Viewed Functionally]
   756   C3542952:Modifier [Intellectual Product]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Because"

Phrase: "efficient utilization of Drosophila"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0042153:utilization [Functional Concept]

Phrase: "as a genetic tool"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0336791:Tool [Manufactured Object]
   861   C2827396:Tool [Manufactured Object]

Phrase: "requires"

Phrase: "simple, robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986815:Robust [Qualitative Concept]

Phrase: "and"

Phrase: "rapid tests for phenotypic modification,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0392366:Tests [Intellectual Product]
   760   C0439831:Rapid [Qualitative Concept]
   726 E C0039593:Test [Functional Concept]

Phrase: "most genetic analyses in the Drosophila"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0679560:genetic analysis [Laboratory Procedure]
   773   C0796344:Genetic Analysis [Laboratory Procedure]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "models of human neurodegenerative diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]

Phrase: "have"

Phrase: "focused on the retina."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C0205234:Focused [Spatial Concept]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
   770   C1285542:focused [Functional Concept]
Processing 00000000.tx.90: However, patients with the majority of the diseases studied do not have prominent retinal pathology; 

Phrase: "However,"

Phrase: "patients with the majority of the diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "prominent retinal pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: ";"
Processing 00000000.tx.91: instead, they show cell loss in specific, largely non-overlapping neuronal subtypes in the cortex, basal ganglia and spinal cord. 

Phrase: "instead,"

Phrase: "they"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cell loss in specific, largely non-overlapping neuronal subtypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1850496:Neuronal loss [Finding]
   742   C1517945:Loss [Quantitative Concept]
   726 E C0598940:neuron loss [Finding]

Phrase: "in the cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "basal ganglia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004781:Basal Ganglia [Body Part, Organ, or Organ Component]
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   861   C0205112:Basal [Spatial Concept]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "and"

Phrase: "spinal cord."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0037925:Spinal Cord [Body Part, Organ, or Organ Component]
  1000   C1278836:Spinal cord [Body Part, Organ, or Organ Component]
   861   C0521329:Spinal [Spatial Concept]
   861   C1550235:Cord [Body Part, Organ, or Organ Component]
   861   C1552938:cord [Quantitative Concept]
   861   C1706500:Cord [Manufactured Object]
Processing 00000000.tx.92: Therefore, we determined whether modifiers of retinal toxicity also modified toxicity to neurons in the brain of Drosophila. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "modifiers of retinal toxicity also modified toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   714   C0205349:Modifier [Qualitative Concept]
   714   C1514623:Modifier [Conceptual Entity]
   714   C1516451:Modifier [Chemical Viewed Functionally]
   714   C3542952:Modifier [Intellectual Product]

Phrase: "to neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.93: We first needed to identify susceptible cell populations in the brain of the fly. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "susceptible cell populations in the brain of the fly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0032659:Population [Quantitative Concept]
   742   C1257890:Population [Population Group]
Processing 00000000.tx.94: We were able to identify vulnerable cell populations in the brain for mutant forms of both ataxin 3 and ataxin 1. 

Phrase: "We"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "identify"

Phrase: "vulnerable cell populations in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0949366:Vulnerable Population [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: "for mutant forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of both ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]
Processing 00000000.tx.95: The substantial toxicity of the Q127 protein limited the analysis of Q127 toxicity in the brain. 

Phrase: "The substantial toxicity of the Q127 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "the analysis of Q127 toxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.96: When mutant ataxin 3 was expressed in neurons of the mushroom body (driver: 30Y-GAL4), neurons were present in normal numbers in 1-day-old flies, but 50% of Kenyon cells degenerated by 30 days (Figs2A, B and 3). 

Phrase: "When"

Phrase: "mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "was"

Phrase: "expressed in neurons of the mushroom body"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0949650:Mushroom Body [Body Part, Organ, or Organ Component]
   757   C0682679:neuron body [Cell Component]
   748   C0001774:Mushroom [Fungus]
   748   C0027882:Neurons [Cell]
   748   C0242821:body [Human]
   748   C0460148:Body [Anatomical Structure]
   748   C0678206:Mushroom [Food]
   748   C1268086:Body [Anatomical Structure]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "30Y-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "present in normal numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in 1-day-old flies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0012578:Flies [Eukaryote]
   779 E C1704307:Fly [Eukaryote]

Phrase: "but"

Phrase: "50% of Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "degenerated by 30 days"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0011164:Degenerated [Pathologic Function]
   770   C0439228:days [Temporal Concept]
   770   C1880269:Degenerated [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "(Figs2A,"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.97: Flies lived about 60 days under our culture conditions. 

Phrase: "Flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]

Phrase: "lived about 60 days"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   737   C1548795:Live [Qualitative Concept]
   737   C1634625:% live [Qualitative Concept]
   737   C2982691:Live [Activity]

Phrase: "under our culture conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.98: Degeneration of Kenyon cells was observed as loss of cells in the cortex (compare cx in Fig.2A and B) and rarefaction of the underlying calyx neuropil (compare n in Fig.2A and B). 

Phrase: "Degeneration of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0333467:cells degeneration [Pathologic Function]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "was"

Phrase: "observed as loss of cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1517945:Loss [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in the cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "cx in Fig.2A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "rarefaction of the underlying calyx neuropil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332550:Rarefaction [Finding]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "n in Fig.2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441922:N+ [Intellectual Product]
   770   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.99: In contrast, expression of expanded ataxin 1 produced no significant degeneration of Kenyon cells when expressed in the same subset of neurons (number of Kenyon cells at 30 days was 1373, P>0.05, compared with 30 day 30Y-GAL4/+ control). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "expression of expanded ataxin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "produced"

Phrase: "no significant degeneration of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0333467:cells degeneration [Pathologic Function]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "when"

Phrase: "expressed in the same subset of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0027882:Neurons [Cell]
   748   C0445247:Same [Qualitative Concept]
   748   C1515021:Subset [Classification]

Phrase: "(number of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "at 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "1373,"

Phrase: "P>0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with 30 day 30Y-GAL4/+ control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0243148:control [Qualitative Concept]
   748   C0332173:/day [Temporal Concept]
   748   C0439228:day [Temporal Concept]
   748   C0439505:/day [Temporal Concept]
   748   C1416832:GAL4 [Gene or Genome]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.100: View larger version (36K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.101: Expression of mutant ataxin 3 produces degeneration of Kenyon cells in the adult brain. 

Phrase: "Expression of mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "produces"

Phrase: "degeneration of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0333467:cells degeneration [Pathologic Function]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "in the adult brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.102: Compare normal numbers of cortical neurons (A, arrow) in a 30-day-old control fly (genotype: 30Y-GAL4/+) with substantial loss of Kenyon cells in a fly expressing mutant ataxin 3 (B, arrow). 

Phrase: "Compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "normal numbers of cortical neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332592:Normal number [Qualitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(A,"

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "in a 30-day-old control fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012578:Fly, NOS [Eukaryote]
   804   C1704307:Fly [Eukaryote]

Phrase: "(genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: ":"

Phrase: "30Y-GAL4/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")"

Phrase: "with substantial loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in a fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012578:Fly, NOS [Eukaryote]
  1000   C1704307:Fly [Eukaryote]

Phrase: "expressing"

Phrase: "mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.103: cx indicates cortex, n indicates neuropil. 

Phrase: "cx"

Phrase: "indicates"

Phrase: "cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: "n"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "indicates"

Phrase: "neuropil."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0228081:Neuropil [Cell Component]
Processing 00000000.tx.104: Expression of human Hsp70 rescues Kenyon cell loss (C, arrow), whereas the EP element EP(2)2510 (D, arrow) enhances neurodegeneration. 

Phrase: "Expression of human Hsp70 rescues Kenyon cell loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C1171362:expression protein [Genetic Function]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "the EP element EP(2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C1705248:Element [Conceptual Entity]

Phrase: ")"

Phrase: "2510"

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.105: Scale bar is 10m. 

Phrase: "Scale bar"

Phrase: "is"

Phrase: "10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.106: Inset in (B) shows TUNEL-positive Kenyon cells (arrows). 

Phrase: "Inset in (B)"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "TUNEL-positive Kenyon cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   875   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.107: Scale bar is 5m.  

Phrase: "Scale bar"

Phrase: "is"

Phrase: "5m."
Processing 00000000.tx.108: View larger version (21K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.109: Quantitative analysis of effects of modifiers on toxicity of mutant ataxin 3 to Kenyon cells (driver: 30Y-GAL4). 

Phrase: "Quantitative analysis of effects of modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "on toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "of mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "to Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "30Y-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.110: All suppressors and the enhancer were significantly different from 30-day-old ataxin 3 transgenic flies, P<0.01, MANOVA with supplementary NewmanKeuls test.  

Phrase: "All suppressors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1710252:Suppressor [Manufactured Object]
   966   C2954564:Suppressor [Pharmacologic Substance]

Phrase: "and"

Phrase: "the enhancer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "significantly different from 30-day-old ataxin 3 transgenic flies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "MANOVA with supplementary NewmanKeuls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0681926:MANOVA [Quantitative Concept]

Phrase: "test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]
Processing 00000000.tx.111: Many of the modifiers that were effective in altering toxicity in the retina also modified toxicity in the brain. 

Phrase: "Many of the modifiers"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "effective in altering toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "in the retina also modified toxicity"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   867   C0877104:retinal toxicity [Anatomical Abnormality]
   812   C0040539:toxicity [Qualitative Concept]
   812   C0600688:Toxicity [Injury or Poisoning]
   741 E C1407029:Toxic [Qualitative Concept]
   719 E C0032346:Poison [Hazardous or Poisonous Substance]
   719 E C1548769:Poison [Intellectual Product]
   719 E C1550590:poison [Idea or Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.112: In particular, expression of heat shock proteins and antiapoptotic proteins produced significant rescue of Kenyon cells (Figs1C and 3). 

Phrase: "In particular, expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of heat shock proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]

Phrase: "and"

Phrase: "antiapoptotic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "significant rescue of Kenyon cells"

Phrase: "(Figs1C"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.113: The role of apoptotic cell death in Kenyon cells was confirmed with TUNEL stains (Fig.2B, inset, arrows). 

Phrase: "The role of apoptotic cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "confirmed with TUNEL stains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig.2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "inset,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.114: No TUNEL-positive cells were observed in non-transgenic controls (Supplementary Material). 

Phrase: "No TUNEL-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed in non-transgenic controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0003069:Transgenic [Animal]
   760   C1441672:Observed [Functional Concept]
   760   C1518422:Non [Functional Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: ")."
Processing 00000000.tx.115: Protection by expression of antiapoptotic proteins was durable with significant rescue extending from 10 to 30 days (Fig.3). 

Phrase: "Protection by expression of antiapoptotic proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "durable with significant rescue extending"

Phrase: "from 10"

Phrase: "to 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.116: Use of an adult assay of neurodegeneration facilitated administration of pharmacologic agents. 

Phrase: "Use of an adult assay of neurodegeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "facilitated"

Phrase: "administration of pharmacologic agents."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C2348003:Agent Administration [Health Care Activity]
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.117: Administration of the histone deacetylase inhibitors sodium butyrate and nicotinamide substantially rescued the neuronal loss (Fig.3). 

Phrase: "Administration of the histone deacetylase inhibitors sodium butyrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nicotinamide substantially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "rescued"

Phrase: "the neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1850496:Neuronal loss [Finding]
   964 E C0598940:neuron loss [Finding]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.118: The strong retinal enhancer EP(2)2510 showed enhancement of neuronal loss with the loss of Kenyon cells and vacuolization of the calyx neuropil (Figs2D and 3). 

Phrase: "The strong retinal enhancer EP(2"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0035298:Retinal [Body Part, Organ, or Organ Component]
   804   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442821:Strong [Qualitative Concept]
   733 E C0237897:Strength [Quantitative Concept]
   733 E C0808080:Strength [Idea or Concept]
   733 E C1705922:Strength [Qualitative Concept]

Phrase: ")"

Phrase: "2510"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhancement of neuronal loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "with the loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "vacuolization of the calyx neuropil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0010840:Vacuolisation [Finding]

Phrase: "(Figs2D"

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.119: No toxicity to Kenyon cells was observed with the expression of EP(2)2510 alone (number of Kenyon cells at 30 days was 1405). 

Phrase: "No toxicity to Kenyon cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "was"

Phrase: "observed with the expression of EP(2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C1441672:Observed [Functional Concept]

Phrase: ")"

Phrase: "2510 alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "(number of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "at 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "1405"

Phrase: ")."
Processing 00000000.tx.120: The retinal enhancer ataxin 2 showed a non-significant trend towards the enhancement of the toxicity of mutant ataxin 3 in Kenyon cells (number of Kenyon cells at 30 days was 594, P>0.05). 

Phrase: "The retinal enhancer ataxin 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0531288:ataxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1538299:ATAXIN 2 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a non-significant trend towards the enhancement of the toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1521798:trend [Temporal Concept]

Phrase: "of mutant ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "in Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(number of Kenyon cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "at 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "594,"

Phrase: "P>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.121: As the expression of mutant ataxin 1 in Kenyon cells using the 30Y-GAL4 driver did not produce significant toxicity, we expressed ataxin 1 in a variety of additional neuronal subpopulations and determined that cholinergic neurons of the lamina were susceptible to ataxin 1 toxicity. 

Phrase: "As the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of mutant ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "in Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 30Y-GAL4 driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0684312:driver [Population Group]
   827   C1556026:Driver [Professional or Occupational Group]
   827   C1705366:Driver [Medical Device]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produce"

Phrase: "significant toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "we"

Phrase: "expressed"

Phrase: "ataxin 1 in a variety of additional neuronal subpopulations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "determined"

Phrase: "that cholinergic neurons of the lamina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2333949:Cholinergic Neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "susceptible to ataxin 1 toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.122: When mutant ataxin 1 was expressed in cholinergic neurons (driver: Cha-GAL4), 50% of these cells degenerated after 30 days (Figs4 and 5). 

Phrase: "When"

Phrase: "mutant ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "was"

Phrase: "expressed in cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C2333949:Cholinergic Neurons [Cell]
   770   C0027882:Neurons [Cell]
   770   C0599668:cholinergic [Functional Concept]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "Cha-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "50% of these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "degenerated after 30 days"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0011164:Degenerated [Pathologic Function]
   770   C0439228:days [Temporal Concept]
   770   C1880269:Degenerated [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "(Figs4"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.123: Figure 4A (arrow) shows well preserved lamina neurons in control flies. 

Phrase: "Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "well preserved lamina neurons in control flies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]
Processing 00000000.tx.124: In the presence of ataxin 1, these neurons were markedly depleted (Fig.4B, arrow indicates large gaps between preserved cholinergic neurons). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ataxin 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "these neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "(Fig.4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "large gaps between preserved cholinergic neurons"

Phrase: ")."
Processing 00000000.tx.125: In contrast to the toxic effects of ataxin l, lamina cholinergic neurons were resistant to the toxicity of mutant ataxin 3 (number of lamina neurons at 30 days was 141, P=0.6 compared with 30 day Cha-GAL4, UAS-GFP/+ control). 

Phrase: "In contrast to the toxic effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   861   C1280500:effects [Qualitative Concept]
   861   C1407029:Toxic [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of ataxin l,"

Phrase: "lamina cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C2333949:Cholinergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "resistant to the toxicity of mutant ataxin 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332325:Resistant to [Functional Concept]
           Resistant
   744   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "(number of lamina neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "at 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "was"

Phrase: "141,"

Phrase: "P=0.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with 30 day Cha-GAL4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C1416832:GAL4 [Gene or Genome]
   753   C1420648:CHA [Gene or Genome]
   753   C1707455:Compared [Activity]

Phrase: "UAS-GFP/+ control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.126: View larger version (27K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.127: Expression of mutant ataxin 1 produces degeneration of cholinergic neurons in the optic lamina. 

Phrase: "Expression of mutant ataxin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "produces"

Phrase: "degeneration of cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]

Phrase: "in the optic lamina."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0920995:Lamina [Body Part, Organ, or Organ Component]
   861   C2330124:Lamina [Body Part, Organ, or Organ Component]
   861   C2700402:Lamina [Plant]
   789 E C0205274:Laminar [Spatial Concept]
Processing 00000000.tx.128: Compare normal numbers of neurons (A, arrow) in a 30-day-old control fly (genotype: Cha-GAL4, UAS-GFP/+) with substantial loss of cholinergic lamina neurons in a fly expressing mutant ataxin 1 (B, arrow). 

Phrase: "Compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "normal numbers of neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332592:Normal number [Qualitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "(A,"

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "in a 30-day-old control fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0012578:Fly, NOS [Eukaryote]
   804   C1704307:Fly [Eukaryote]

Phrase: "(genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: ":"

Phrase: "Cha-GAL4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "UAS-GFP/+) with substantial loss of cholinergic lamina neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "in a fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012578:Fly, NOS [Eukaryote]
  1000   C1704307:Fly [Eukaryote]

Phrase: "expressing"

Phrase: "mutant ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.129: Expression of Drosophila Hdj1 (C) or treatment with nicotinamide (D) rescues lamina degeneration. 

Phrase: "Expression of Drosophila Hdj1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "treatment with nicotinamide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "D)"

Phrase: "rescues"

Phrase: "lamina degeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.130: Scale bar is 10m. 

Phrase: "Scale bar"

Phrase: "is"

Phrase: "10m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.131: Inset in (B) shows TUNEL-positive lamina neuron. 

Phrase: "Inset in (B)"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "TUNEL-positive lamina neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neuron [Cell]
   741 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.132: Scale bar is 5m.  

Phrase: "Scale bar"

Phrase: "is"

Phrase: "5m."
Processing 00000000.tx.133: View larger version (15K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.134: Quantitative analysis of effects of modifiers on toxicity of mutant ataxin 1 to cholinergic neurons (driver: Cha-GAL4). 

Phrase: "Quantitative analysis of effects of modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0392762:Quantitative [Quantitative Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "on toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "of mutant ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "to cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "Cha-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.135: All suppressors were significantly different from 30-day-old ataxin 1 flies, P<0.01, MANOVA with supplementary NewmanKeuls test.  

Phrase: "All suppressors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1710252:Suppressor [Manufactured Object]
   966   C2954564:Suppressor [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly different from 30-day-old ataxin 1 flies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705242:Different [Qualitative Concept]

Phrase: "P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "MANOVA with supplementary NewmanKeuls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0681926:MANOVA [Quantitative Concept]

Phrase: "test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]
Processing 00000000.tx.136: As with the modification of ataxin 3 toxicity in Kenyon cells, overexpression of chaperones and antiapoptotic proteins produced significant rescue of ataxin 1 toxicity in the lamina (Figs4 and 5). 

Phrase: "As with the modification of ataxin 3 toxicity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1538301:ATAXIN 3 [Gene or Genome]
   744   C0040539:toxicity [Qualitative Concept]
   744   C0392747:Modification [Functional Concept]
   744   C0600688:Toxicity [Injury or Poisoning]
   744   C1554963:modification [Qualitative Concept]

Phrase: "in Kenyon cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpression of chaperones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "antiapoptotic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "significant rescue of ataxin 1 toxicity"

Phrase: "in the lamina"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0920995:Lamina [Body Part, Organ, or Organ Component]
  1000   C2330124:Lamina [Body Part, Organ, or Organ Component]
  1000   C2700402:Lamina [Plant]
   928 E C0205274:Laminar [Spatial Concept]

Phrase: "(Figs4"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.137: The role of apoptosis was confirmed by performing TUNEL staining (Fig.4B, inset, arrow). 

Phrase: "The role of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "was"

Phrase: "confirmed by performing TUNEL staining"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0487602:Staining [Laboratory Procedure]
   760   C0600528:TUNEL [Molecular Biology Research Technique]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1704680:Staining [Finding]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig.4B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "inset,"

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.138: No TUNEL-positive cells were observed in non-transgenic controls (Supplementary Material). 

Phrase: "No TUNEL-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "observed in non-transgenic controls"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0003069:Transgenic [Animal]
   760   C1441672:Observed [Functional Concept]
   760   C1518422:Non [Functional Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: ")."
Processing 00000000.tx.139: Oral administration of the histone deacetylase inhibitors sodium butyrate and nicotinamide also produced significant rescue (Fig.5). 

Phrase: "Oral administration of the histone deacetylase inhibitors sodium butyrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0001563:Administration, Oral [Therapeutic or Preventive Procedure]
   762   C0357155:Oral sodium [Clinical Drug]
   742   C0001554:Administration [Occupational Activity]
   742   C0442027:Oral [Spatial Concept]
   742   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "nicotinamide also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "produced"

Phrase: "significant rescue"

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.140: Although dSir2, tara and pum all significantly enhanced ataxin 1 toxicity in the eye, none showed enhancement of toxicity to cholinergic neurons of the lamina (Table 1). 

Phrase: "Although"

Phrase: "dSir2,"

Phrase: "tara"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1823497:TARA [Gene or Genome]
  1000   C2309431:Tara [Plant]

Phrase: "and"

Phrase: "pum"

Phrase: "all significantly enhanced ataxin 1 toxicity in the eye,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0040539:toxicity [Qualitative Concept]
   742   C0600688:Toxicity [Injury or Poisoning]
   734   C1262036:ocular toxicity [Injury or Poisoning]

Phrase: "none"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "enhancement of toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   790   C2349975:Enhancement [Activity]

Phrase: "to cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of the lamina"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0920995:Lamina [Body Part, Organ, or Organ Component]
  1000   C2330124:Lamina [Body Part, Organ, or Organ Component]
  1000   C2700402:Lamina [Plant]
   928 E C0205274:Laminar [Spatial Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.141: Overexpression of dSir2 and pum likely accounts for the enhancement of toxicity in the eye by the respective EP element insertions because loss of function alleles fail to show enhancement (9). 

Phrase: "Overexpression of dSir2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "pum likely"

Phrase: "accounts for the enhancement of toxicity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]
   753   C1551359:account [Idea or Concept]
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "in the eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0015392:Eye [Body Part, Organ, or Organ Component]
  1000   C1280202:Eye [Body Part, Organ, or Organ Component]
   944 E C0029144:optic [Occupation or Discipline]
   944 E C0042789:Ocular [Organism Function]
   944 E C1299003:Ocular [Spatial Concept]
   907 E C0014236:Ophthalmia [Disease or Syndrome]
   907 E C0700042:Oculus [Body Location or Region]

Phrase: "by the respective EP element insertions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441587:insertions [Health Care Activity]
   779 E C0021107:Insertion [Therapeutic or Preventive Procedure]
   779 E C1512796:Insertion [Genetic Function]
   779 E C1883719:Insertion [Functional Concept]

Phrase: "because"

Phrase: "loss of function alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.142: tara likely modifies by a loss of function mechanism as enhancement is seen with independent loss of function alleles (9). 

Phrase: "tara"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1823497:TARA [Gene or Genome]
  1000   C2309431:Tara [Plant]

Phrase: "likely"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]
   928 E C0033204:Likelihood [Quantitative Concept]

Phrase: "modifies by a loss of function mechanism"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0031843:function [Physiologic Function]
   748   C0392747:MODIFY [Functional Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1517945:Loss [Quantitative Concept]
   748   C1705273:Function [Intellectual Product]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "as enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "is"

Phrase: "seen with independent loss of function alleles"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   774   C0332291:Independent of [Functional Concept]
   748   C0002085:Alleles [Gene or Genome]
   748   C0031843:function [Physiologic Function]
   748   C0085862:Independent [Idea or Concept]
   748   C0205397:Seen [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1299583:Independent [Finding]
   748   C1517945:Loss [Quantitative Concept]
   748   C1705273:Function [Intellectual Product]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.143: Enhancement of ataxin 1 toxicity to cholinergic neurons by Atx2 and EP(2)2510 appeared likely because ataxin 1 flies carrying these modifiers died prior to eclosion. 

Phrase: "Enhancement of ataxin 1 toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "to cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "by Atx2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538299:ATX2 [Gene or Genome]

Phrase: "and"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2510"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "because"

Phrase: "ataxin 1 flies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0012578:Flies [Eukaryote]
   793 E C1704307:Fly [Eukaryote]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "these modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "died prior to eclosion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0011065:Died [Organism Function]
   770   C1160232:eclosion [Organism Function]
   770   C1546956:Died [Finding]
   770   C2826257:PRIOR [Event]
Processing 00000000.tx.144: Modifiers isolated as suppressors or enhancers of ataxin 1, ataxin 3 or tau have no effect on the levels of these proteins in the eye (3,9,14). 

Phrase: "Modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "isolated as suppressors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756   C1710252:Suppressor [Manufactured Object]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   756   C2954564:Suppressor [Pharmacologic Substance]

Phrase: "or"

Phrase: "enhancers of ataxin 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0086222:Enhancer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "or"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "have"

Phrase: "no effect on the levels of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "in the eye"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0015392:Eye [Body Part, Organ, or Organ Component]
  1000   C1280202:Eye [Body Part, Organ, or Organ Component]
   944 E C0029144:optic [Occupation or Discipline]
   944 E C0042789:Ocular [Organism Function]
   944 E C1299003:Ocular [Spatial Concept]
   907 E C0014236:Ophthalmia [Disease or Syndrome]
   907 E C0700042:Oculus [Body Location or Region]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "9,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.145: To ensure that the modifiers showing effect in our brain assays (Figs3 and 5) did not alter ataxin 1 or ataxin 3 expression in the brain, we used immunofluorescence analysis to monitor ataxin 1 and ataxin 3 levels in the presence of the genetic modifiers shown in Figures 3 and 5 and following treatment with sodium butyrate or vitamin B3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "effect in our brain assays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(Figs3"

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "or"

Phrase: "ataxin 3 expression in the brain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence analysis to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "ataxin 3 levels in the presence of the genetic modifiers"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0456949:Level 3 [Intellectual Product]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "shown in Figures 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with sodium butyrate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "vitamin B3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]
Processing 00000000.tx.146: We used immunofluorescence to evaluate expression levels, because aggregation of the expanded polyglutamine proteins complicates analysis on western blots (3,9). 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "expression levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "because"

Phrase: "aggregation of the expanded polyglutamine proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332621:Aggregation [Functional Concept]
   753   C0439168:% aggregation [Quantitative Concept]

Phrase: "complicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:complicate [Functional Concept]

Phrase: "analysis on western blots"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   865   C0949466:Western blot analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.147: No changes in the levels of ataxin 1 or ataxin 3 were detected, suggesting that the genetic modifiers and drug treatments did not alter toxicity by simply increasing or decreasing the levels of the polyglutamine proteins.  

Phrase: "No changes in the levels of ataxin 1"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   754   C0442739:No change [Finding]
   754   C1548568:No change [Intellectual Product]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1538301:ATAXIN 3 [Gene or Genome]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the genetic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "drug treatments"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "toxicity by simply increasing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "or"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the levels of the polyglutamine proteins."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.148: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  The overall goal of this study was to determine whether common pathways of toxicity govern neurodegenerative cell death in the eye and brain in the Drosophila models of human neurodegenerative diseases. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The overall goal of this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018017:Goal [Intellectual Product]
   753   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "common pathways of toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "govern"

Phrase: "neurodegenerative cell death in the eye"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "brain in the Drosophila"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "models of human neurodegenerative diseases."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]
Processing 00000000.tx.149: Using a large number of previously reported genetic modifiers (3,4,9,11,14), we found that many modifiers did work in multiple models and in cells of both the retina and the brain. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a large number of previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "genetic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "9,"

Phrase: "11,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "many modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "did"

Phrase: "work in multiple models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043227:Work [Occupational Activity]
   770   C0439064:Multiple [Quantitative Concept]
   770   C3161035:Models [Intellectual Product]

Phrase: "and in cells of both"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.150: Overexpression of chaperone proteins was generally beneficial in polyglutamine disorders, correlating with results in the mouse model of SCA1 (5). 

Phrase: "Overexpression of chaperone proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "was"

Phrase: "generally beneficial in polyglutamine disorders,"

Phrase: "correlating with results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "in the mouse model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2986594:Mouse Model [Experimental Model of Disease]
   861   C3161035:Model [Intellectual Product]

Phrase: "of SCA1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.151: Similarly, expression of antiapoptotic proteins protected against the toxicity of some polyglutamine proteins and against tau toxicity. 

Phrase: "Similarly,"

Phrase: "expression of antiapoptotic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1171362:expression protein [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "protected against the toxicity of some polyglutamine proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040539:toxicity [Qualitative Concept]
   744   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   744   C0600688:Toxicity [Injury or Poisoning]
   731   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and against tau toxicity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
   770   C1515981:And [Idea or Concept]
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
Processing 00000000.tx.152: We confirmed the role of apoptosis in these disorders directly with TUNEL stains (Figs2 and 4). 

Phrase: "We"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the role of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in these disorders directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "with TUNEL stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Figs2"

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.153: Apoptosis has also been implicated in human disorders (17). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "implicated in human disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012634:Disorders [Disease or Syndrome]
   770   C0086418:Human [Human]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.154: Two modifiers were recovered that represent strong candidates for common mediators. 

Phrase: "Two modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "that"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "strong candidates for common mediators."
Processing 00000000.tx.155: Overexpression of ataxin 2 and a mutation in the novel gene CG7231 enhanced toxicity in all models, and had similar effects in both the retina and the brain. 

Phrase: "Overexpression of ataxin 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "and"

Phrase: "a mutation in the novel gene CG7231"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0596611:Gene Mutation [Genetic Function]
   774   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "toxicity in all models,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "had"

Phrase: "similar effects in both"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.156: Ataxin 2 is the Drosophila homolog of a protein that has an abnormal polyglutamine expansion in SCA2. 

Phrase: "Ataxin 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0531288:ataxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538299:ATAXIN 2 [Gene or Genome]

Phrase: "is"

Phrase: "the Drosophila homolog of a protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]
   753   C1334043:Homolog [Gene or Genome]

Phrase: "that"

Phrase: "has"

Phrase: "an abnormal polyglutamine expansion in SCA2."
Processing 00000000.tx.157: The normal function of ataxin 2 is not known, but roles in regulation of the actin cytoskeleton (18) and Golgi integrity (19) have been suggested. 

Phrase: "The normal function of ataxin 2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "roles in regulation of the actin cytoskeleton"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "Golgi integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "(19"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "suggested."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]
Processing 00000000.tx.158: A conserved homolog of CG7231 is present in humans, but the sequence motifs that might suggest a possible function for the predicted protein are not present. 

Phrase: "A conserved homolog of CG7231"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homolog [Gene or Genome]

Phrase: "is"

Phrase: "present in humans,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "the sequence motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "that"

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a possible function for the predicted protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0815043:function protein [Amino Acid, Peptide, or Protein]
   774   C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]
Processing 00000000.tx.159: Unlike ataxin 2, a significant stretch of polyglutamines is not predicted from CG7231. 

Phrase: "Unlike ataxin 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0531288:ataxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538299:ATAXIN 2 [Gene or Genome]

Phrase: "a significant stretch of polyglutamines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "predicted from CG7231."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0681842:Predicted [Idea or Concept]
   790   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.160: In addition to potentially informative commonalities among the effects of the modifiers on the models we tested, a number of differences emerged from our studies. 

Phrase: "In addition to potentially informative commonalities"

Phrase: "among the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of the modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "on the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "a number of differences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "emerged from our studies."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.161: Surprisingly, neither p35 nor thread expression suppressed retinal cell death produced by the expression of Q127. 

Phrase: "Surprisingly,"

Phrase: "neither p35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539715:p35 [Gene or Genome]

Phrase: "nor"

Phrase: "thread expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "retinal cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007587:Cell Death [Cell Function]
   901   C2338017:Retinal cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "produced by the expression of Q127."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.162: Both the mediators worked well in the ataxin 3 and ataxin 1 models, as well as in the tauopathy model (14,16). 

Phrase: "Both"

Phrase: "the mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   966 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "worked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:worked [Occupational Activity]

Phrase: "well in the ataxin 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "ataxin 1 models,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C3161035:Models [Intellectual Product]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "as well as in the tauopathy model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C0949664:Tauopathy [Disease or Syndrome]
   748   C3146287:Well [Manufactured Object]
   748   C3161035:Model [Intellectual Product]

Phrase: "(14,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.163: These findings suggest that a different mechanism of cell death may be operating in the case of Q127-mediated retinal toxicity. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a different mechanism of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C1708951:Mechanism of Cell Death [Cell Function]
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "operating in the case of Q127-mediated retinal toxicity."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0877104:retinal toxicity [Anatomical Abnormality]
   742   C0035298:Retinal [Body Part, Organ, or Organ Component]
   742   C0040539:toxicity [Qualitative Concept]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0600688:Toxicity [Injury or Poisoning]
   742   C0868928:Case [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]
   708   C3242339:operate [Functional Concept]
Processing 00000000.tx.164: The failure of p35 and thread expression to rescue retinal cell death does not rule out an apoptotic mechanism, because there appears to be apoptotic cell death that is caspase independent. 

Phrase: "The failure of p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231174:Failure [Functional Concept]
   770   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "thread expression to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "rescue"

Phrase: "retinal cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007587:Cell Death [Cell Function]
   901   C2338017:Retinal cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "an apoptotic mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "because"

Phrase: "there"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "caspase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "independent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0085862:Independent [Idea or Concept]
  1000   C1299583:Independent [Finding]
Processing 00000000.tx.165: However, the distinction from the other polyglutamine models does suggest a protein context dependence of the final cell death pathway, despite what would appear to be similar triggering mechanisms and a similar sensitivity to other modifiers like the heat shock proteins. 

Phrase: "However,"

Phrase: "the distinction from the"

Phrase: "other polyglutamine models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "does"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a protein context dependence of the final cell death pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0011546:Dependence [Mental Process]
   739   C0439857:Dependence [Mental or Behavioral Dysfunction]
   739   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "despite what"

Phrase: "would"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "similar triggering mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "a similar sensitivity to other modifiers"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "like the heat shock proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0018850:Heat shock proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0282498:Heat Shock [Physiologic Function]
   827   C0018837:Heat [Natural Phenomenon or Process]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0036974:Shock [Pathologic Function]
Processing 00000000.tx.166: Indeed, context dependence is one of the most intriguing features of polyglutamine disorders. 

Phrase: "Indeed,"

Phrase: "context dependence"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "is"

Phrase: "one of the most intriguing features of polyglutamine disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]
Processing 00000000.tx.167: The proteins containing the expanded polyglutamine tracts neither share any sequence similarity nor have the same subcellular localization. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the expanded polyglutamine tracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1185740:tracts [Body Part, Organ, or Organ Component]

Phrase: "neither"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "any sequence similarity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710052:Sequence Similarity [Quantitative Concept]
   861   C2348205:Similarity [Qualitative Concept]

Phrase: "nor"

Phrase: "have"

Phrase: "the same subcellular localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]
Processing 00000000.tx.168: The normal functions of most of the proteins are unknown. 

Phrase: "The normal functions of most of the proteins"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   767   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   744   C0542341:Functions [Functional Concept]
   734 E C1527118:Protein Function [Molecular Function]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "are"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.169: However, in all these diseases a critical expansion of a polyglutamine tract confers toxicity on the protein. 

Phrase: "However,"

Phrase: "in all"

Phrase: "these diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Diseases [Disease or Syndrome]
   928 E C1836721:MALS [Finding]
   928 E C3538764:MALS [Gene or Genome]
   928 E C3540595:MAL [Gene or Genome]

Phrase: "a critical expansion of a polyglutamine tract"

Phrase: "confers"

Phrase: "toxicity on the protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.170: As the human diseases are so different, the context of the polyglutamine expansion is clearly crucial. 

Phrase: "As the human diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "are"

Phrase: "so different,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1705242:Different [Qualitative Concept]
   789 E C1705241:*Difference [Quantitative Concept]
   761 E C0443199:Differential [Qualitative Concept]

Phrase: "the context of the polyglutamine expansion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]

Phrase: "is"

Phrase: "clearly crucial."
Processing 00000000.tx.171: Genetic studies have yet to identify candidates that might mediate this difference. 

Phrase: "Genetic studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C2827447:Genetic Study [Research Activity]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "yet to"

Phrase: "identify"

Phrase: "candidates"

Phrase: "that"

Phrase: "might"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "this difference."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.172: This comparative study suggests that the modifiers showing ataxin 1-specific effects, dSir2, tara and pum, may represent such genes, at least in the retina. 

Phrase: "This comparative study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009491:Comparative Study [Intellectual Product]
  1000   C1579762:comparative study [Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "ataxin 1-specific effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "dSir2,"

Phrase: "tara"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1823497:TARA [Gene or Genome]
  1000   C2309431:Tara [Plant]

Phrase: "and"

Phrase: "pum,"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "such genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in the retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.173: We examined the sensitivity of neurons in the brain of the fly to polyglutamine proteins, because selective vulnerability of particular subsets of central neurons, not typically including the retinal cells, is a hallmark of neurodegenerative disorders. 

Phrase: "We"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the sensitivity of neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of the fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012578:Fly, NOS [Eukaryote]
  1000   C1704307:Fly [Eukaryote]

Phrase: "to polyglutamine proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "because"

Phrase: "selective vulnerability of particular subsets of central neurons,"

Phrase: "not typically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the retinal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2338017:Retinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a hallmark of neurodegenerative disorders."
Processing 00000000.tx.174: In contrast, most analysis in the Drosophila models of neurodegenerative diseases has been performed in the retina to harness the power of rapid genetic testing. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "most analysis in the Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "models of neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   802   C0683033:disease model [Intellectual Product]
   802   C0684309:Disease model [Experimental Model of Disease]
   770   C0012634:Diseases [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "performed in the retina to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0035298:Retina [Body Part, Organ, or Organ Component]
   760   C0884358:Performed [Functional Concept]
   760   C1278894:Retina [Body Part, Organ, or Organ Component]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "harness"

Phrase: "the power of rapid genetic testing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0814897:power testing [Research Activity]
   753   C0032863:Power [Human-caused Phenomenon or Process]
Processing 00000000.tx.175: Many of these studies have been done using an expression system that drives production of the toxic human proteins in both photoreceptors and non-neuronal cells (driver: GMR-GAL4), raising the possibility that some of the effects seen could be due to the toxicity in non-neuronal cells. 

Phrase: "Many of these studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an expression system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "that"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "production of the toxic human proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "in both photoreceptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031760:Photoreceptors [Cell]

Phrase: "and"

Phrase: "non-neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(driver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684312:driver [Population Group]
  1000   C1556026:Driver [Professional or Occupational Group]
  1000   C1705366:Driver [Medical Device]

Phrase: ":"

Phrase: "GMR-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that"

Phrase: "some of the effects"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C1280500:effects [Qualitative Concept]
   770   C3540770:Some [Intellectual Product]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "could"

Phrase: "be due to the toxicity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "in non-neuronal cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0027836:Non-neuronal cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: Reassuringly, we find that the major classes of modifiers previously recovered, the molecular chaperones and antiapoptotic proteins, work well in postmitotic neurons in the fly brain. 

Phrase: "Reassuringly,"

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "the major classes of modifiers previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456387:Class [Intellectual Product]
   753   C1705943:Class [Classification]

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: ","

Phrase: "the molecular chaperones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "and"

Phrase: "antiapoptotic proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "well in postmitotic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "in the fly brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.177: However, effects in the retina did not always predict effects in the brain. 

Phrase: "However,"

Phrase: "effects in the retina"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "did"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "predict"

Phrase: "effects in the brain."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.178: dSir2, tara and pum substantially enhanced ataxin 1 toxicity in the retina, but had no clear effects in the brain. 

Phrase: "dSir2,"

Phrase: "tara"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1823497:TARA [Gene or Genome]
  1000   C2309431:Tara [Plant]

Phrase: "and"

Phrase: "pum substantially enhanced ataxin 1 toxicity in the retina,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0040539:toxicity [Qualitative Concept]
   742   C0600688:Toxicity [Injury or Poisoning]
   726   C0877104:retinal toxicity [Anatomical Abnormality]

Phrase: "but"

Phrase: "had"

Phrase: "no clear effects in the brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1301751:No effect [Qualitative Concept]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.179: In fact, decreasing the dose of dSir2, a histone deacetylase, enhanced ataxin 1 toxicity in the eye, whereas pharmacologic inhibitors of histone deacetylase rescued toxicity to cholinergic neurons in the brain (Fig.5). 

Phrase: "In fact,"

Phrase: "decreasing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0442797:Decreasing [Qualitative Concept]
   966 E C0392756:Decrease [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "the dose of dSir2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178602:Dose [Quantitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]

Phrase: "a histone deacetylase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhanced ataxin 1 toxicity in the eye,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]
   746   C1262036:ocular toxicity [Injury or Poisoning]

Phrase: "whereas"

Phrase: "pharmacologic inhibitors of histone deacetylase rescued toxicity"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C1512474:Histone Deacetylase Inhibitors [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C2266853:Histone Deacetylase Inhibitors [Molecular Function]
   788 E C3537120:Histone Deacetylase Inhibitor [Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "to cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.180: Our laboratory has previously shown specific cell-type vulnerability in the Drosophila models of Parkinson's disease (15) and tauopathy (20). 

Phrase: "Our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "has"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "specific cell-type vulnerability in the Drosophila"

Phrase: "models of Parkinson's disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0683033:disease model [Intellectual Product]
   819   C0684309:Disease model [Experimental Model of Disease]
   770   C0012634:Disease [Disease or Syndrome]
   770   C3161035:Model [Intellectual Product]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "tauopathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathy [Disease or Syndrome]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.181: We now demonstrate similar effects in ataxin 3 and ataxin 1 models. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "demonstrate"

Phrase: "similar effects in ataxin 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "ataxin 1 models."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C3161035:Models [Intellectual Product]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]
Processing 00000000.tx.182: Expression of expanded ataxin 3 caused clear toxicity to Kenyon cells, the projection neurons of the mushroom bodies. 

Phrase: "Expression of expanded ataxin 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "clear toxicity to Kenyon cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "the projection neurons of the mushroom bodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   757   C0085103:neuron projection [Cell Component]
   748   C0016538:Projection [Intellectual Product]
   748   C0027882:Neurons [Cell]
   748   C0033363:Projection [Mental Process]
   748   C0348018:Projection [Spatial Concept]
   745 E C0682698:Projection neuron [Cell]
   741   C0682679:neuron body [Cell Component]
Processing 00000000.tx.183: These structures are implicated in learning and memory. 

Phrase: "These structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "implicated in learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013621:learning [Educational Activity]
   790   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025260:Memory [Mental Process]
  1000   C0700327:memory [Finding]
  1000   C1706377:Memory [Manufactured Object]
   944 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.184: In contrast, Kenyon cells were resistant to ataxin 1 toxicity. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Kenyon cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resistant to ataxin 1 toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.185: Conversely, cholinergic neurons of the lamina were sensitive to ataxin 1 toxicity, but not susceptible to the effects of mutant ataxin 3. 

Phrase: "Conversely,"

Phrase: "cholinergic neurons of the lamina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2333949:Cholinergic Neurons [Cell]
   760   C0027882:Neurons [Cell]

Phrase: "were"

Phrase: "sensitive to ataxin 1 toxicity,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0040539:toxicity [Qualitative Concept]
   804   C0600688:Toxicity [Injury or Poisoning]
   733 E C1407029:Toxic [Qualitative Concept]
   711 E C0032346:Poison [Hazardous or Poisonous Substance]
   711 E C1548769:Poison [Intellectual Product]
   711 E C1550590:poison [Idea or Concept]

Phrase: "but"

Phrase: "not susceptible to the effects of mutant ataxin 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0231204:Susceptible [Functional Concept]
   742   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.186: These effects likely represent differences in the intrinsic vulnerability of these cell types rather than differences in levels of protein expression, given the reciprocal nature of the effects. 

Phrase: "These effects likely"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "differences in the intrinsic vulnerability of these cell types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "rather than"

Phrase: "differences in levels of protein expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the reciprocal nature of the effects."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]
Processing 00000000.tx.187: Interestingly, cholinergic anterior horn cells show consistently severe degeneration in patients with SCA1 (8). 

Phrase: "Interestingly,"

Phrase: "cholinergic anterior horn cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   923   C0003154:Anterior Horn Cells [Cell]
   902   C1183202:Cholinergic cells [Cell]
   861   C0228590:Anterior horn [Body Part, Organ, or Organ Component]
   827   C1275629:horn cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0019939:Horn [Body Part, Organ, or Organ Component]
   812   C0205094:Anterior [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "consistently severe degeneration in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "with SCA1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   861   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   861   C0441729:Type 1 [Classification]
   812   C0004134:Ataxia [Sign or Symptom]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]
   741 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.188: The brain assays we describe are simple and robust and provide the basis for the investigation of cell-type vulnerability in these disorders. 

Phrase: "The brain assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "describe"

Phrase: "are"

Phrase: "simple"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205352:Simple [Qualitative Concept]

Phrase: "and"

Phrase: "robust"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986815:Robust [Qualitative Concept]

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "the basis for the investigation of cell-type vulnerability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1527178:Basis [Functional Concept]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "in these disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.189: In the current study, use of the brain assays facilitated testing of histone deacetylase as a common mediator of polyglutamine toxicity and identification of a common vitamin, vitamin B3, as a potent and general suppressor of polyglutamine toxicity. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "use of the brain assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1524063:Use of [Functional Concept]
   760   C0042153:use [Functional Concept]
   760   C0457083:Use [Functional Concept]
   760   C1947944:Use [Intellectual Product]

Phrase: "facilitated"

Phrase: "testing of histone deacetylase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0039593:Testing [Functional Concept]
   770   C0392366:testing [Intellectual Product]
   770   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0022885:Test [Laboratory Procedure]

Phrase: "as a common mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of polyglutamine toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "and"

Phrase: "identification of a common vitamin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "vitamin B3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: "as"

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "general suppressor of polyglutamine toxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1710252:Suppressor [Manufactured Object]
   760   C2954564:Suppressor [Pharmacologic Substance]
Processing 00000000.tx.190: Effects of drugs on adult onset retinal degeneration may be seen following the oral administration (11). 

Phrase: "Effects of drugs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   988   C0728866:effect of drugs [Functional Concept]
           drug effects
   824 E C0728867:Drug effect [Pathologic Function]
   824 E C1411996:drug effect [Biologic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on adult onset retinal degeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2751770:Retinal degeneration, adult-onset [Finding]
   861   C0035304:Retinal Degeneration [Disease or Syndrome]
   812   C0011164:Degeneration [Pathologic Function]
   812   C0035298:Retinal [Body Part, Organ, or Organ Component]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the oral administration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001563:Administration, Oral [Therapeutic or Preventive Procedure]
   861   C0001554:Administration [Occupational Activity]
   861   C0442027:Oral [Spatial Concept]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.191: However, ensuring adequate dosing during larval and pupal development can be problematic, when attempting to treat eye pathologies that develop prior to eclosion (Fig.1). 

Phrase: "However,"

Phrase: "ensuring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0218063:Ensure [Food]

Phrase: "adequate dosing during larval"

Phrase: "and"

Phrase: "pupal development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1523658:pupal development [Physiologic Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "problematic,"

Phrase: "when"

Phrase: "attempting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "eye pathologies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   955   C1518542:Ocular Pathology [Biomedical Occupation or Discipline]
   861   C0030664:Pathologies [Biomedical Occupation or Discipline]
   827 E C0205469:pathology [Functional Concept]
   827 E C0677042:pathology [Pathologic Function]
   777 E C1521733:Pathologic [Functional Concept]

Phrase: "that"

Phrase: "develop prior to eclosion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C1160232:eclosion [Organism Function]
   770   C2826257:PRIOR [Event]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.192: We circumvented this difficulty by using an adult brain assay. 

Phrase: "We"

Phrase: "circumvented"

Phrase: "this difficulty by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1299586:Difficulty [Finding]
   718 E C0332218:Difficult [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an adult brain assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.193: Using the brain assay, we were able to see clear effects of the histone deacetylase inhibitor sodium butyrate on degeneration of adult neurons caused by expanded ataxin 3 or ataxin 1. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the brain assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "clear effects of the histone deacetylase inhibitor sodium butyrate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "of adult neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "caused by expanded ataxin 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0205229:expanded [Spatial Concept]
   726   C0015127:cause [Functional Concept]
   726   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "ataxin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]
Processing 00000000.tx.194: In addition, we demonstrated significant protective effects of nicotinamide (vitamin B3). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "significant protective effects of nicotinamide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "(vitamin B3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.195: Nicotinamide has recently been shown to be strong inhibitor of histone deacetylase (21). 

Phrase: "Nicotinamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "strong inhibitor of histone deacetylase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1512474:Histone deacetylase inhibitor [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   844   C2266853:Histone Deacetylase Inhibitor [Molecular Function]
   844   C3537120:Histone Deacetylase Inhibitor [Pharmacologic Substance]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.196: Other activities of nicotinamide are also known, including inhibition of poly(ADP-ribose) polymerase (22), but as the drug has previously been used in clinical trials (23,24) and has strong effects in two separate models of postmitotic neuronal polyglutamine toxicity, it may represent a therapeutic possibility even in the absence of unequivocal identification of its molecular target. 

Phrase: "Other activities of nicotinamide"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   816   C2712604:Other activity [Daily or Recreational Activity]
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "also"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "inhibition of poly(ADP-ribose) polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0032405:Poly ADP Ribose Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   716   C1538577:POLY(ADP-RIBOSE) POLYMERASE [Gene or Genome]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "but as the drug"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0013227:Drug [Pharmacologic Substance]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C1254351:Drug [Pharmacologic Substance]
   715 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   715 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "used in clinical trials"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0008976:Clinical Trials [Research Activity]
           Trial
   833   C1096775:clinical trials [Intellectual Product]
   770   C0205210:Clinical [Qualitative Concept]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "strong effects in two separate models of postmitotic neuronal polyglutamine toxicity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]
   701   C0600688:Toxic effect [Injury or Poisoning]

Phrase: "it"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a therapeutic possibility even in the absence of unequivocal identification"

Phrase: "of its molecular target."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.197: Using a brain assay also allowed us to determine whether the prevention of apoptosis is a reliable method for rescuing neurons on a long-term basis. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "also"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the prevention of apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "is"

Phrase: "a reliable method for rescuing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "on a long-term basis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1527178:Basis [Functional Concept]
   812   C1874451:Basis [Pharmacologic Substance]
Processing 00000000.tx.198: Previous work has suggested that blocking apoptosis may result in only a brief rescue of neuronal viability, with other mechanisms of cell death intervening eventually (25). 

Phrase: "Previous work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that blocking apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "may"

Phrase: "result in only"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205171:Only [Quantitative Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1720467:Only [Intellectual Product]
   790   C2825142:Result [Finding]

Phrase: "a brief rescue of neuronal viability,"

Phrase: "with other mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "of cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "intervening"

Phrase: "eventually"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.199: In contrast, we find a long lasting, durable effect of blocking apoptosis by using the antiapoptotic proteins p35 and thread. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "a long lasting,"

Phrase: "durable effect of blocking apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the antiapoptotic proteins p35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3539715:p35 [Gene or Genome]
   734   C1565114:Anti-Apoptotic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "thread."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710394:Thread [Manufactured Object]
  1000   C1882475:Thread [Intellectual Product]
Processing 00000000.tx.200: Cells were rescued from 10 to 30 days of life, a significant period for an organism with a lifespan of 60 days. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rescued from 10"

Phrase: "to 30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "a significant period for an organism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]

Phrase: "with a lifespan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0870809:life span [Group Attribute]

Phrase: "of 60 days."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.201: These data suggest that antiapoptotic therapies may provide sustained benefit in neurodegenerative disorders. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that antiapoptotic therapies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "sustained benefit in neurodegenerative disorders."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefit [Quantitative Concept]
Processing 00000000.tx.202: In summary, we demonstrate that three pathways previously implicated in the Drosophila models of human neurodegenerative diseases, protein folding, histone acetylation and apoptosis are common features of neurotoxicity in several disease models and generalize from the retina to the brain. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that three pathways previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "implicated in the Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013138:Drosophila [Eukaryote]
   770   C1028876:Drosophila [Fungus]
   770   C1504613:Drosophila [Eukaryote]

Phrase: "models of human neurodegenerative diseases,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]

Phrase: "protein folding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162847:protein folding [Molecular Function]
   861   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "histone acetylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156200:Histone Acetylation [Molecular Function]
   861   C0001038:Acetylation [Molecular Function]
   861   C1521754:Acetylation [Molecular Function]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "common features of neurotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]

Phrase: "in several disease models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683033:disease models [Intellectual Product]
   901   C0684309:disease models [Experimental Model of Disease]
   827   C3161035:Models [Intellectual Product]

Phrase: "and"

Phrase: "generalize from the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "to the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.203: However, we also determine that none of these pathways operates in all the models examined, but instead suggest that the two novel modifiers are better candidates for common mediators. 

Phrase: "However,"

Phrase: "we also"

Phrase: "determine"

Phrase: "that"

Phrase: "none of these pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "operates in all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3242339:operate [Functional Concept]

Phrase: "the models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "but"

Phrase: "instead"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the two novel modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0205349:Modifier [Qualitative Concept]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "are"

Phrase: "better candidates for common mediators."
Processing 00000000.tx.204: In addition, we demonstrate clear cell-type vulnerability in ataxin 3 and ataxin 1 models and show that some modifiers have retina-specific effects. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "clear cell-type vulnerability in ataxin 3"

Phrase: "and"

Phrase: "ataxin 1 models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C3161035:Models [Intellectual Product]
   734   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "some modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "have"

Phrase: "retina-specific effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.205: Use of novel assays of neurotoxicity in specific postmitotic neurons in the adult brain facilitated the identification of a common dietary supplement, vitamin B3, as a potential candidate therapeutic for polyglutamine disorders, including the SCAs and Huntington's disease. 

Phrase: "Use of novel assays of neurotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "in specific postmitotic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in the adult brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "facilitated"

Phrase: "the identification of a common dietary supplement,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "vitamin B3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: "as"

Phrase: "a potential candidate"

Phrase: "therapeutic for polyglutamine disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   770   C0302350:Therapeutic [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the SCAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0149575:SCA [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "Huntington's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0020179:Huntington Disease [Disease or Syndrome]
  1000   C2919056:Huntington's Disease [Functional Concept]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.206: Using these assays, we also demonstrate a sustained protective effect of inhibition of apoptosis on neuronal viability.  

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "these assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "we also"

Phrase: "demonstrate"

Phrase: "a sustained protective effect of inhibition of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on neuronal viability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443348:viability [Qualitative Concept]
Processing 00000000.tx.207: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Fly stocks All stocks were maintained on standard cornmeal-based Drosophila medium at 25C. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Fly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012578:Fly, NOS [Eukaryote]
  1000   C1704307:Fly [Eukaryote]

Phrase: "stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]

Phrase: "All stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "maintained on standard cornmeal-based Drosophila medium"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   748   C0009458:Medium [Intellectual Product]
   748   C0013138:Drosophila [Eukaryote]
   748   C0439536:Medium [Quantitative Concept]
   748   C0458983:Cornmeal [Food]
   748   C1028876:Drosophila [Fungus]
   748   C1314677:Maintained [Functional Concept]
   748   C1442989:Standard [Qualitative Concept]
   748   C1504613:Drosophila [Eukaryote]
   748   C1527178:Based [Functional Concept]
   748   C1705217:Medium [Substance]
   748   C1705938:Based [Idea or Concept]
   748   C2828392:Standard [Intellectual Product]
   748   C3244283:medium [Intellectual Product]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0024501:Maintain [Activity]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "at 25C."
Processing 00000000.tx.208: The following Drosophila models of human neurodegenerative diseases were used: UAS-SCA3-78 (2), UAS-SCA1-82 (15) and UAS-Q127 (4). 

Phrase: "The following Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013138:Drosophila [Eukaryote]
   861   C1028876:Drosophila [Fungus]
   861   C1504613:Drosophila [Eukaryote]

Phrase: "models of human neurodegenerative diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   781   C0683033:disease model [Intellectual Product]
   781   C0684309:Disease model [Experimental Model of Disease]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C0086418:Human [Human]
   760   C3161035:Model [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "UAS-SCA3-78"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0024408:Spinocerebellar Ataxia Type 3 [Disease or Syndrome]
           Spinocerebellar Ataxia-3
   827   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0441731:Type 3 [Classification]
   799   C0004134:Ataxia [Sign or Symptom]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   727 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "UAS-SCA1-82"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0752120:Spinocerebellar Ataxia Type 1 [Disease or Syndrome]
           Spinocerebellar Ataxia-1
   827   C0087012:Ataxia, Spinocerebellar [Disease or Syndrome]
   827   C0441729:Type 1 [Classification]
   799   C0004134:Ataxia [Sign or Symptom]
   799   C0332307:Type [Qualitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   727 E C0234366:Ataxic [Sign or Symptom]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "UAS-Q127"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.209: The GAL4 driver lines used include: 30Y-GAL4 (26), Cha-GAL4 (20) and GMR-GAL4 (27). 

Phrase: "The GAL4 driver lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: ":"

Phrase: "30Y-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "(26"

Phrase: ")"

Phrase: ","

Phrase: "Cha-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "(20"

Phrase: ")"

Phrase: "and"

Phrase: "GMR-GAL4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.210: The following modifier transgenes and mutants previously identified as modifiers of polyglutamine toxicity were tested: UAS-HSP70 and UAS-HSC4DN(3); 

Phrase: "The following modifier transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgenes [Gene or Genome]

Phrase: "and"

Phrase: "mutants previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "identified as modifiers of polyglutamine toxicity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   753   C0600688:Toxicity [Injury or Poisoning]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   719   C0205349:Modifier [Qualitative Concept]
   719   C1514623:Modifier [Conceptual Entity]
   719   C1516451:Modifier [Chemical Viewed Functionally]
   719   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "UAS-HSP70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1415760:HSP70 [Gene or Genome]
   861   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "UAS-HSC4DN"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.211: UAS-DNAJ1 and UAS-Tpr (4); 

Phrase: "UAS-DNAJ1"

Phrase: "and"

Phrase: "UAS-Tpr (4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1098484:TPR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1420877:TPR [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.212: UAS-P35 (28); 

Phrase: "UAS-P35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539715:p35 [Gene or Genome]

Phrase: "(28"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.213: EP(2)2231, EP(2)2417, EP(2)2300, EP(3)3672, EP(3)3623, EP(3)3378, EP(3)3725, EP(3)3461, EP(3)3463, EP(3)674, P(3)292, P(3)1666, EP(3)411, EU3500, EP(X)1303 (9); 

Phrase: "EP(2"

Phrase: ")"

Phrase: "2231,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2417,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2300,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3672,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3623,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3378,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3725,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3461,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3463,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "674,"

Phrase: "P(3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "292,"

Phrase: "P(3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "1666,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "411,"

Phrase: "EU3500,"

Phrase: "EP(X)1303"

Phrase: "(9"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.214: UAS-DTS5 (10) and Sin3A8264 (11). 

Phrase: "UAS-DTS5"

Phrase: "(10"

Phrase: ")"

Phrase: "and"

Phrase: "Sin3A8264"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.215: The following transgenes and mutants were identified in the forward genetic screen for modifiers of tau toxicity (14) and were tested in the ataxin 3, ataxin 1 and Q127 models: EP(X)1455, EP(3)1246, EP(3)3319, EP(3)3518, EP(3)3559, EP(3)3569, EP(3)1072, EP(3)3308, EP(3)3145, EP(3)3517, EP(3)3265, EP(3)581, EP(3)326, EP(3)3403, EP(3)1213, EP(2)2500, EP(2)613, EP(2)2504, EP(2)2208, EP(2)712, EP(2)2028, EP(2)2090, EP(2)2311, EP(2)2475, EP(2)2510, EP(2)2190, EP(2)2437, EP(2)899, UAS-Atx2, UAS-wun, UAS-dFmr1, UAS-th and UAS-par1. 

Phrase: "The following transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgenes [Gene or Genome]

Phrase: "and"

Phrase: "mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified in the forward genetic screen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0813145:Genetic screen [Diagnostic Procedure]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0205396:Identified [Qualitative Concept]
   753   C0220908:screen [Health Care Activity]
   753   C0314603:Genetic [Functional Concept]
   753   C0439780:Forward [Spatial Concept]
   753   C1305399:screen [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "for modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0205349:Modifier [Qualitative Concept]
   966   C1514623:Modifier [Conceptual Entity]
   966   C1516451:Modifier [Chemical Viewed Functionally]
   966   C3542952:Modifier [Intellectual Product]

Phrase: "of tau toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "tested in the ataxin 3,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C1538301:ATAXIN 3 [Gene or Genome]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "ataxin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0380755:ataxin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538298:ATAXIN 1 [Gene or Genome]

Phrase: "and"

Phrase: "Q127 models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: ":"

Phrase: "EP(X)1455,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "1246,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3319,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3518,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3559,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3569,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "1072,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3308,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3145,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3517,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3265,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "581,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "326,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "3403,"

Phrase: "EP(3"

Phrase: ")"

Phrase: "1213,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2500,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "613,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2504,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2208,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "712,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2028,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2090,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2311,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2475,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2510,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2190,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "2437,"

Phrase: "EP(2"

Phrase: ")"

Phrase: "899,"

Phrase: "UAS-Atx2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1538299:ATX2 [Gene or Genome]

Phrase: "UAS-wun,"

Phrase: "UAS-dFmr1,"

Phrase: "UAS-th"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "and"

Phrase: "UAS-par1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366449:PAR-1 [Gene or Genome]
   861   C1414387:PAR-1 [Gene or Genome]
Processing 00000000.tx.216: In the cases where both an EP strain and a corresponding UAS transgene were available, both were tested and similar results were obtained. 

Phrase: "In the cases where"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "both an EP strain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0080194:Strain [Injury or Poisoning]
   861   C0456178:strain [Intellectual Product]
   861   C1518614:Strain [Organism]
   861   C2987481:Strain [Mental Process]

Phrase: "and"

Phrase: "a corresponding UAS transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282641:Transgene [Gene or Genome]

Phrase: "were"

Phrase: "available,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "both"

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.217: Control flies carried the appropriate GAL4 driver in the heterozygous state (genotypes: 30Y-GAL4/+, Cha-GAL4, UAS-GFP/+ and GMR-GAL4/+. 

Phrase: "Control flies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012578:Flies [Eukaryote]
   827 E C1704307:Fly [Eukaryote]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the appropriate GAL4 driver in the heterozygous state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0684312:driver [Population Group]
   744   C1556026:Driver [Professional or Occupational Group]
   744   C1705366:Driver [Medical Device]

Phrase: "(genotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotypes [Organism Attribute]

Phrase: ":"

Phrase: "30Y-GAL4/+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "Cha-GAL4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]

Phrase: "UAS-GFP/+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "GMR-GAL4/+."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416832:GAL4 [Gene or Genome]
Processing 00000000.tx.218: Retinas were examined at 1 day following eclosion. 

Phrase: "Retinas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035298:Retinas [Body Part, Organ, or Organ Component]
   966 E C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "at 1 day"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332173:/day [Temporal Concept]
   827   C0439228:day [Temporal Concept]
   827   C0439505:/day [Temporal Concept]
   734   C1412113:AT-1 [Gene or Genome]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "eclosion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1160232:eclosion [Organism Function]
Processing 00000000.tx.219: Drosophila were fed 150mM sodium butyrate or 100mM nicotinamide (vitamin B3) in instant Drosophila medium (Carolina). 

Phrase: "Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "150mM sodium butyrate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0142812:Sodium Butyrate [Lipid,Pharmacologic Substance]
   827   C0006521:butyrate [Lipid]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0220802:butyrate [Lipid]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "or"

Phrase: "100mM nicotinamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(vitamin B3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028027:Vitamin B3 [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C2349968:B3+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "in instant Drosophila medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "(Carolina"

Phrase: ")."
Processing 00000000.tx.220: Histology and immunohistochemistry Adult flies were fixed in formalin at 1, 10 and 30 days following eclosion, dehydrated and embedded in paraffin. 

Phrase: "Histology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019638:Histology [Biomedical Occupation or Discipline]
  1000   C0205462:histology [Functional Concept]
  1000   C0344441:Histology [Laboratory Procedure]

Phrase: "and"

Phrase: "immunohistochemistry Adult flies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1440070:Adult fly [Immunologic Factor]
   827   C0012578:Flies [Eukaryote]
   793 E C1704307:Fly [Eukaryote]

Phrase: "were"

Phrase: "fixed in formalin at 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0231441:Fixed [Finding]
   760   C0443218:Fixed [Qualitative Concept]
   760   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C2827483:Fixed [Body Substance]

Phrase: "10"

Phrase: "and"

Phrase: "30 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "eclosion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1160232:eclosion [Organism Function]

Phrase: "dehydrated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011175:Dehydrated [Disease or Syndrome]

Phrase: "and"

Phrase: "embedded in paraffin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0085185:embedded paraffin [Laboratory Procedure]
   790   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   790   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.221: Sections were cut at 4m thickness and either stained with hematoxylin and eosin, immunostained, or used in TUNEL assays. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "cut at 4m thickness"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0000925:Cut [Injury or Poisoning]
   770   C1280412:Thickness [Qualitative Concept]
   770   C1883724:CUT [Phenomenon or Process]

Phrase: "and"

Phrase: "either"

Phrase: "stained with hematoxylin"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0018964:Haematoxylin stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Haematoxylin
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "eosin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014448:Eosin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C0885297:eosin [Organic Chemical,Pharmacologic Substance]

Phrase: "immunostained"

Phrase: ","

Phrase: "or"

Phrase: "used in TUNEL assays."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C1515232:TUNEL Assay [Molecular Biology Research Technique]
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   770   C1273517:used [Finding]
   737   C0005507:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737   C0243073:assay [Qualitative Concept]
   737 E C0457083:Use [Functional Concept]
   737   C1510438:Assay [Laboratory Procedure]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.222: Immunostaining on paraffin sections was performed using either the avidinbiotinperoxidase method or immunofluorescence. 

Phrase: "Immunostaining on paraffin sections"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either"

Phrase: "the avidinbiotinperoxidase method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "or"

Phrase: "immunofluorescence."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.223: An anti-GFP antibody from Chemicon was used at a dilution of 1:5000. 

Phrase: "An anti-GFP antibody from Chemicon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used at a dilution of 1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1273517:used [Finding]
   753   C1948037:Dilution [Functional Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "5000."
Processing 00000000.tx.224: An anti-HA antibody from Sigma was used at a concentration of 1:5000 to detect HA-tagged ataxin 3. 

Phrase: "An anti-HA antibody from Sigma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used at a concentration of 1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0086045:Concentration [Mental Process]
   753   C1273517:used [Finding]
   753   C1446561:Concentration [Quantitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "5000 to"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "HA-tagged ataxin 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1332071:HA-3 [Gene or Genome]
   861   C1538301:ATAXIN 3 [Gene or Genome]
Processing 00000000.tx.225: An anti-ataxin 1 antisera (kind gift of H. Zoghbi) was used at a concentration of 1:250. 

Phrase: "An anti-ataxin 1 antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(kind gift of H. Zoghbi"

Phrase: ")"

Phrase: "was"

Phrase: "used at a concentration of 1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0086045:Concentration [Mental Process]
   753   C1273517:used [Finding]
   753   C1446561:Concentration [Quantitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "250."
Processing 00000000.tx.226: TUNEL staining was performed according to the manufacturer's protocol (Oncogene research products: TdT-FragEL DNA fragmentation detection kit). 

Phrase: "TUNEL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed according to the manufacturer's protocol"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0442711:Protocol [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0884358:Performed [Functional Concept]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C1705426:Manufacturer [Population Group]
   753   C2348563:Protocol [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Oncogene research products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0029005:Oncogene Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: ":"

Phrase: "TdT-FragEL DNA fragmentation detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0812225:KIT [Medical Device]
   799   C1150635:KIT [Molecular Function]
   799   C1705212:Kit [Medical Device]
   799   C1705213:KIT [Medical Device]
   799   C3273202:Kit [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.227: To evaluate Kenyon cell loss, the number of cells in a defined 35m area in well-oriented frontal sections was counted on hematoxylin and eosin stained sections. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "Kenyon cell loss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517945:Loss [Quantitative Concept]

Phrase: "the number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in a defined 35m area in well-oriented frontal sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0205123:Frontal [Spatial Concept]
   760   C0205155:Section [Spatial Concept]
   760   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   760   C1522472:Section [Substance]
   760   C1552923:Section [Quantitative Concept]
   760   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "counted on hematoxylin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "eosin stained sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
Processing 00000000.tx.228: At least eight hemibrains were counted per genotype and time point. 

Phrase: "At least eight hemibrains"

Phrase: "were"

Phrase: "counted per genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017431:Genotype [Organism Attribute]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.229: Quantitation of cholinergic neurons in the optic lamina was performed on brain sections immunostained for GFP as an independent marker. 

Phrase: "Quantitation of cholinergic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "in the optic lamina"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0920995:Lamina [Body Part, Organ, or Organ Component]
   861   C2330124:Lamina [Body Part, Organ, or Organ Component]
   861   C2700402:Lamina [Plant]
   789 E C0205274:Laminar [Spatial Concept]

Phrase: "was"

Phrase: "performed on brain sections"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0884358:Performed [Functional Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunostained for GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "as an independent marker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.230: The number of lamina cholinergic neurons per 70m length was determined in well-oriented sections. 

Phrase: "The number of lamina cholinergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "per 70m length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "in well-oriented sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0205155:Section [Spatial Concept]
   779   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   779   C1522472:Section [Substance]
   779   C1552923:Section [Quantitative Concept]
   779   C1705191:Section [Physical Object]
Processing 00000000.tx.231: At least eight hemibrains were examined per genotype and time point. 

Phrase: "At least eight hemibrains"

Phrase: "were"

Phrase: "examined per genotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017431:Genotype [Organism Attribute]
   790   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.232: All data shown are significant with P<0.01, MANOVA with supplementary NewmanKeuls test.  

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "significant with P<0.01,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0237881:significant [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "MANOVA with supplementary NewmanKeuls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0681926:MANOVA [Quantitative Concept]

Phrase: "test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]
Processing 00000000.tx.233: SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Supplementary Material is available at HMG Online.  

Phrase: "SUPPLEMENTARY MATERIAL TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Supplementary Material"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2936424:Supplementary Material [Intellectual Product]
   861   C0520510:Material [Substance]

Phrase: "is"

Phrase: "available at HMG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "Online."
Processing 00000000.tx.234: ACKNOWLEDGEMENTS  We thank David Sinclair for sharing unpublished data. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "David Sinclair for sharing unpublished data."
Processing 00000000.tx.235: We are indebted to Nancy Bonini, Parsa Kazemi-Esfarjani, the Bloomington Stock Center and Exelixis for providing stocks. 

Phrase: "We"

Phrase: "are"

Phrase: "indebted to Nancy Bonini,"

Phrase: "Parsa Kazemi-Esfarjani,"

Phrase: "the Bloomington Stock Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Exelixis for providing stocks."
Processing 00000000.tx.236: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.237: Zoghbi generously provided the anti-ataxin 1 antibody. 

Phrase: "Zoghbi generously"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the anti-ataxin 1 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.238: This work was supported by grants from the NIH (AG88001 and AG19790) to M.B.F.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the NIH (AG88001"

Phrase: "and"

Phrase: "AG19790"

Phrase: ")"

Phrase: "to M.B.F."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1306057:M-F [Temporal Concept]
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.239: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.240: Tel: +1 6175254405; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 6175254405"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.241: Fax: +1 6175254422; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 6175254422"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.242: Email: mel_feany{at}hms.harvard.edu Present address: Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.  

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "mel_feany{at}hms.harvard.edu Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0376649:Address [Intellectual Product]
   793   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Cancer Genetics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0587466:Genetics department [Health Care Related Organization]
   770   C1704729:Department [Organization]
   715   C0694768:genetics of cancer [Biomedical Occupation or Discipline]

Phrase: "Roswell Park Cancer Institute,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519110:Roswell Park Cancer Institute [Health Care Related Organization]
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Buffalo,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006352:Buffalo [Mammal]
  1000   C0324533:BUFFALO [Mammal]
  1000   C1739095:Buffalo [Mammal]

Phrase: "NY 14263,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.243: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS SUPPLEMENTARY MATERIAL REFERENCES  Trojanowski, J.Q. and Lee, V.M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS SUPPLEMENTARY MATERIAL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2936424:Supplementary Material [Intellectual Product]
   827   C0520510:Material [Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.244: (2000) Fatal attractions of proteins. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Fatal attractions of proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   816   C0309048:FATAL ATTRACTION [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.245: A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. 

Phrase: "A comprehensive hypothetical mechanism underlying Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0002395:Alzheimer's Disease [Disease or Syndrome]
   827   C1521724:Alzheimer's Disease [Pathologic Function]
   799   C0012634:Disease [Disease or Syndrome]
   743 E C1836721:MALS [Finding]
   743 E C3538764:MALS [Gene or Genome]
   743 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "other neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.246: Ann. 

Phrase: "Ann."
Processing 00000000.tx.247: N.Y. 

Phrase: "N.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.248: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.249: Sci., 924, 6267.[Abstract/Free FullText] Warrick, J.M., Paulson, H.L., Gray-Board, G.L., Bui, Q.T., Fischbeck, K.H., Pittman, R.N. and Bonini, N.M. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "924,"

Phrase: "6267."

Phrase: "[Abstract/Free FullText"

Phrase: "] Warrick,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Paulson,"

Phrase: "H.L., Gray-Board,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0972401:board [Medical Device]
   812   C1948070:Board [Organization]

Phrase: "G.L., Bui,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0439294:g l [Quantitative Concept]

Phrase: "Q.T.,"

Phrase: "Fischbeck,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pittman,"

Phrase: "R.N."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0687673:R.N. [Professional or Occupational Group]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.250: (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Expanded polyglutamine protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "nuclear inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1366904:Nuclear Inclusions [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neural degeneration in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0027746:neural degeneration [Cell or Molecular Dysfunction]
   770   C0011164:Degeneration [Pathologic Function]
   770   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.251: Cell, 93, 939949.[ISI][Medline] Warrick, J.M., Chan, H.Y., Gray-Board, G.L., Chai, Y., Paulson, H.L. and Bonini, N.M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "93,"

Phrase: "939949."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Warrick,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Chan,"

Phrase: "H.Y.,"

Phrase: "Gray-Board,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0972401:board [Medical Device]
   861   C1948070:Board [Organization]

Phrase: "G.L., Chai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0439294:g l [Quantitative Concept]

Phrase: "Y.,"

Phrase: "Paulson,"

Phrase: "H.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346686:h l [Quantitative Concept]

Phrase: "and"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.252: (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Suppression of polyglutamine-mediated neurodegeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "in Drosophila"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]

Phrase: "by the molecular chaperone HSP70."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415760:HSP70 [Gene or Genome]
   827   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.253: Nat. 

Phrase: "Nat."
Processing 00000000.tx.254: Genet., 23, 425428.[CrossRef][ISI][Medline] Kazemi-Esfarjani, P. and Benzer, S. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "425428."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kazemi-Esfarjani,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Benzer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.255: (2000) Genetic suppression of polyglutamine toxicity in Drosophila. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Genetic suppression of polyglutamine toxicity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0038855:Suppression, Genetic [Genetic Function]
   760   C0221103:Suppression [Pathologic Function]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]

Phrase: "in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.256: Science, 287, 18371840.[Abstract/Free FullText] Cummings, C.J., Sun, Y., Opal, P., Antalffy, B., Mestril, R., Orr, H.T., Dillmann, W.H. and Zoghbi, H.Y. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "287,"

Phrase: "18371840."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cummings,"

Phrase: "C.J.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Opal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0084990:OPAL [Therapeutic or Preventive Procedure]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Antalffy,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mestril,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Orr,"

Phrase: "H.T.,"

Phrase: "Dillmann,"

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Zoghbi,"

Phrase: "H.Y."
Processing 00000000.tx.257: (2001) Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Over-expression of inducible HSP70 chaperone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205136:Over [Spatial Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "improves"

Phrase: "motor function in SCA1 mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0234130:Motor function [Functional Concept]
   767   C0278161:Ataxia, Motor [Sign or Symptom]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1513492:Motor [Functional Concept]
   744   C1705273:Function [Intellectual Product]
   744   C1705994:Motor [Manufactured Object]
Processing 00000000.tx.258: Hum. 

Phrase: "Hum."
Processing 00000000.tx.259: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.260: Genet., 10, 15111518.[Abstract/Free FullText] Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M. and Bonini, N.M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "15111518."

Phrase: "[Abstract/Free FullText"

Phrase: "] Auluck,"

Phrase: "P.K.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Chan,"

Phrase: "H.Y.,"

Phrase: "Trojanowski,"

Phrase: "J.Q., Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.261: (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Chaperone suppression of alpha-synuclein toxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221103:Suppression [Pathologic Function]
   753   C0301625:Suppression [Organism Function]
   753   C0439181:% suppression [Quantitative Concept]
   753   C0728721:suppression [Mental Process]

Phrase: "in a Drosophila model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "for Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.262: Science, 295, 865868.[Abstract/Free FullText] Taylor, J.P., Hardy, J. and Fischbeck, K.H. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "295,"

Phrase: "865868."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taylor,"

Phrase: "J.P.,"

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Fischbeck,"

Phrase: "K.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.263: (2002) Toxic proteins in neurodegenerative disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Toxic proteins in neurodegenerative disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0815048:toxic proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.264: Science, 296, 19911995.[Abstract/Free FullText] De Girolami, U. and Feany, M.B. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "296,"

Phrase: "19911995."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Girolami,"

Phrase: "U."

Phrase: "and"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.265: (2000) Degenerative diseases of the cerebellum. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Degenerative diseases of the cerebellum."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0007760:Cerebellum Diseases [Disease or Syndrome]
   773   C1285162:Degenerative Disease [Disease or Syndrome]
   760   C0011164:Degenerative [Pathologic Function]
   760   C0012634:Diseases [Disease or Syndrome]
   760   C1880269:Degenerative [Functional Concept]
Processing 00000000.tx.266: In Duckett, J.C. and de la Torre, J.C. 

Phrase: "In Duckett,"

Phrase: "J.C."

Phrase: "and"

Phrase: "de la Torre,"

Phrase: "J.C."
Processing 00000000.tx.267: (eds), Pathology of the Aging Human Nervous System. 

Phrase: "(eds"

Phrase: ")"

Phrase: ","

Phrase: "Pathology of the Aging Human Nervous System."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1512513:Human Pathology [Biomedical Occupation or Discipline]
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.268: Oxford University Press, New York, pp. 

Phrase: "Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "pp."
Processing 00000000.tx.269: 332359. 

Phrase: "332359."
Processing 00000000.tx.270: Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She, W.C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P.J. etal. 

Phrase: "Fernandez-Funez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nino-Rosales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524901:Rosales [Plant]

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "de Gouyon,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "She,"

Phrase: "W.C., Luchak,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Martinez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Turiegano,"

Phrase: "E.,"

Phrase: "Benito,"

Phrase: "J.,"

Phrase: "Capovilla,"

Phrase: "M."

Phrase: ","

Phrase: "Skinner,"

Phrase: "P.J. etal."
Processing 00000000.tx.271: (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Identification of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "that"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "ataxin-1-induced neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.272: Nature, 408, 101106.[CrossRef][ISI][Medline] Chan, H.Y., Warrick, J.M., Andriola, I., Merry, D. and Bonini, N.M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "408,"

Phrase: "101106."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chan,"

Phrase: "H.Y.,"

Phrase: "Warrick,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Andriola,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Merry,"

Phrase: "D."

Phrase: "and"

Phrase: "Bonini,"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.273: (2002) Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genetic modulation of polyglutamine toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "by protein conjugation pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.274: Hum. 

Phrase: "Hum."
Processing 00000000.tx.275: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.276: Genet., 11, 28952904.[Abstract/Free FullText] Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "28952904."

Phrase: "[Abstract/Free FullText"

Phrase: "] Steffan,"

Phrase: "J.S.,"

Phrase: "Bodai,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Pallos,"

Phrase: "J.,"

Phrase: "Poelman,"

Phrase: "M."

Phrase: ","

Phrase: "McCampbell,"

Phrase: "A.,"

Phrase: "Apostol,"

Phrase: "B.L., Kazantsev,"

Phrase: "A.,"

Phrase: "Schmidt,"

Phrase: "E.,"

Phrase: "Zhu,"

Phrase: "Y.Z.,"

Phrase: "Greenwald,"

Phrase: "M. etal."
Processing 00000000.tx.277: (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Histone deacetylase inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1512474:Histone Deacetylase Inhibitors [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C2266853:Histone Deacetylase Inhibitors [Molecular Function]
   966 E C3537120:Histone Deacetylase Inhibitor [Pharmacologic Substance]
   901   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "arrest"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0237477:Arrest [Temporal Concept]
  1000   C0392351:arrest [Governmental or Regulatory Activity]
   944 E C0311403:Inhibited [Qualitative Concept]
   944 E C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "polyglutamine-dependent neurodegeneration in Drosophila."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.278: Nature, 413, 739743.[CrossRef][ISI][Medline] Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N.W., Ratan, R.R., Luthi-Carter, R. and Hersch, S.M. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "413,"

Phrase: "739743."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ferrante,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kubilus,"

Phrase: "J.K.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346601:J/K [Quantitative Concept]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "J.,"

Phrase: "Ryu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Beesen,"

Phrase: "A.,"

Phrase: "Zucker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700303:Zucker [Mammal]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kowall,"

Phrase: "N.W., Ratan,"

Phrase: "R.R.,"

Phrase: "Luthi-Carter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hersch,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.279: (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Histone deacetylase inhibition by sodium butyrate chemotherapy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "ameliorates"

Phrase: "the neurodegenerative phenotype in Huntington's disease mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.280: J. 

Phrase: "J."
Processing 00000000.tx.281: Neurosci., 23, 94189427.[Abstract/Free FullText] Hockly, E., Richon, V.M., Woodman, B., Smith, D.L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P.A. etal. 

Phrase: "Neurosci.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "94189427."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hockly,"

Phrase: "E.,"

Phrase: "Richon,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Woodman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."

Phrase: "L., Zhou,"

Phrase: "X.,"

Phrase: "Rosa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035853:Rosa [Plant]

Phrase: "E.,"

Phrase: "Sathasivam,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ghazi-Noori,"

Phrase: "S."

Phrase: ","

Phrase: "Mahal,"

Phrase: "A.,"

Phrase: "Lowden,"

Phrase: "P.A. etal."
Processing 00000000.tx.282: (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Suberoylanilide hydroxamic acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0672708:suberoylanilide hydroxamic acid [Organic Chemical,Pharmacologic Substance]
   901   C0020314:Hydroxamic Acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "a histone deacetylase inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512474:Histone deacetylase inhibitor [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C2266853:Histone Deacetylase Inhibitor [Molecular Function]
  1000   C3537120:Histone Deacetylase Inhibitor [Pharmacologic Substance]
   901   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "ameliorates"

Phrase: "motor deficits in a mouse model of Huntington's disease."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0746626:deficits motor [Pathologic Function]
   742   C2987487:deficits [Qualitative Concept]
   708 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.283: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.284: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.285: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.286: USA, 100, 20412046.[Abstract/Free FullText] Shulman, J.M. and Feany, M.B. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "20412046."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shulman,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: (2003) Genetic modifiers of tauopathy in Drosophila. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Genetic modifiers of tauopathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0205349:Modifier [Qualitative Concept]
   737   C1514623:Modifier [Conceptual Entity]
   737   C1516451:Modifier [Chemical Viewed Functionally]
   737   C3542952:Modifier [Intellectual Product]

Phrase: "in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013138:Drosophila [Eukaryote]
  1000   C1028876:Drosophila [Fungus]
  1000   C1504613:Drosophila [Eukaryote]
Processing 00000000.tx.288: Genetics, 165, 12331242.[Abstract/Free FullText] Feany, M.B. and Bender, W.W. 

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "165,"

Phrase: "12331242."

Phrase: "[Abstract/Free FullText"

Phrase: "] Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "W.W."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709500:%W/W [Quantitative Concept]
  1000   C2919747:w/w [Quantitative Concept]
Processing 00000000.tx.289: (2000) A Drosophila model of Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "A Drosophila model of Parkinson's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.290: Nature, 404, 394398.[CrossRef][ISI][Medline] Jackson, G.R., Wiedau-Pazos, M., Sang, T.K., Wagle, N., Brown, C.A., Massachi, S. and Geschwind, D.H. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "404,"

Phrase: "394398."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jackson,"

Phrase: "G.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wiedau-Pazos,"

Phrase: "M."

Phrase: ","

Phrase: "Sang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1864650:SANG [Gene or Genome]

Phrase: "T.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Wagle,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "C."

Phrase: "A.,"

Phrase: "Massachi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Geschwind,"

Phrase: "D."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.291: (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Human wild-type tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720655:Tau [Intellectual Product]
   812   C1947974:Tau [Research Activity]

Phrase: "interacts with wingless pathway components"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0449432:Components [Manufactured Object]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "produces"

Phrase: "neurofibrillary pathology in Drosophila."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
Processing 00000000.tx.292: Neuron, 34, 509519.[ISI][Medline] Evert, B.O., Wullner, U. and Klockgether, T. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "34,"

Phrase: "509519."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "Evert"

Phrase: ","

Phrase: "B.O.,"

Phrase: "Wullner,"

Phrase: "U."

Phrase: "and"

Phrase: "Klockgether,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.293: (2000) Cell death in polyglutamine diseases. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cell death in polyglutamine diseases."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.294: Cell Tissue Res., 301, 189204.[CrossRef][ISI][Medline] Satterfield, T.F., Jackson, S.M. and Pallanck, L.J. 

Phrase: "Cell Tissue Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: "301,"

Phrase: "189204."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Satterfield,"

Phrase: "T.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Jackson,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Pallanck,"

Phrase: "L.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.295: (2002) A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. 

Phrase: "(2002"

Phrase: ")"

Phrase: "A Drosophila homolog of the polyglutamine disease gene SCA2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1334043:Gene Homolog [Gene or Genome]
           Homolog

Phrase: "is"

Phrase: "a dosage-sensitive regulator of actin filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0182953:REGULATOR [Medical Device]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.296: Genetics, 162, 16871702.[Abstract/Free FullText] Huynh, D.P., Yang, H.T., Vakharia, H., Nguyen, D. and Pulst, S.M. 

Phrase: "Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017398:Genetics [Biomedical Occupation or Discipline]
  1000   C0017399:genetics [Biologic Function]

Phrase: "162,"

Phrase: "16871702."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H.T.,"

Phrase: "Vakharia,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nguyen,"

Phrase: "D."

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.297: (2003) Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Expansion of the polyQ repeat"

Phrase: "in ataxin-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0531288:ataxin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538299:ATAXIN 2 [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its Golgi localization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1660008:Golgi localisation [Cell Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the Golgi complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Complex [Cell Component]
           Golgi
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.298: Hum. 

Phrase: "Hum."
Processing 00000000.tx.299: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.300: Genet., 12, 14851496.[Abstract/Free FullText] Wittmann, C.W., Wszolek, M.F., Shulman, J.M., Salvaterra, P.M., Lewis, J., Hutton, M. and Feany, M.B. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "14851496."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wittmann,"

Phrase: "C.W., Wszolek,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shulman,"

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Salvaterra,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Lewis,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Feany,"

Phrase: "M.B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: (2001) Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Tauopathy in Drosophila"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0949664:Tauopathy [Disease or Syndrome]

Phrase: ":"

Phrase: "neurodegeneration without neurofibrillary tangles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.302: Science, 293, 711714.[Abstract/Free FullText] Bitterman, K.J., Anderson, R.M., Cohen, H.Y., Latorre-Esteves, M. and Sinclair, D.A. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "711714."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bitterman,"

Phrase: "K.J.,"

Phrase: "Anderson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Cohen,"

Phrase: "H.Y.,"

Phrase: "Latorre-Esteves,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Sinclair,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.303: (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Inhibition of silencing"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "accelerated aging by nicotinamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001811:Ageing [Organism Function]

Phrase: "a putative negative regulator of yeast sir2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0182953:REGULATOR [Medical Device]
   748   C0205160:Negative [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C1704734:Regulator [Medical Device]
   748   C1704735:Regulator [Conceptual Entity]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "human SIRT1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1423062:SIRT1 [Gene or Genome]
Processing 00000000.tx.304: J. 

Phrase: "J."
Processing 00000000.tx.305: Biol. 

Phrase: "Biol."
Processing 00000000.tx.306: Chem., 277, 4509945107.[Abstract/Free FullText] Virag, L. and Szabo, C. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "4509945107."

Phrase: "[Abstract/Free FullText"

Phrase: "] Virag,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Szabo,"

Phrase: "C."
Processing 00000000.tx.307: (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The therapeutic potential of poly(ADP-ribose) polymerase inhibitors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.308: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.309: Rev., 54, 375429.[Abstract/Free FullText] Crino, A., Schiaffini, R., Manfrini, S., Mesturino, C., Visalli, N., Beretta Anguissola, G., Suraci, C., Pitocco, D., Spera, S., Corbi, S. etal. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "54,"

Phrase: "375429."

Phrase: "[Abstract/Free FullText"

Phrase: "] Crino,"

Phrase: "A.,"

Phrase: "Schiaffini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Manfrini,"

Phrase: "S."

Phrase: ","

Phrase: "Mesturino,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Visalli,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Beretta Anguissola,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Suraci,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pitocco,"

Phrase: "D."

Phrase: ","

Phrase: "Spera,"

Phrase: "S."

Phrase: ","

Phrase: "Corbi,"

Phrase: "S. etal."
Processing 00000000.tx.310: IMDIAB group. 

Phrase: "IMDIAB group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.311: (2004) A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX). 

Phrase: "(2004"

Phrase: ")"

Phrase: "A randomized trial of nicotinamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008976:Trial [Research Activity]

Phrase: "and"

Phrase: "vitamin E in children"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   777 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "with recent onset type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0011854:Type 1 diabetes [Disease or Syndrome]
   853   C1320657:type diabetes [Finding]
   840   C0441729:Type 1 [Classification]
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0332307:Type [Qualitative Concept]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(IMDIAB IX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015491:IX [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.312: Eur. 

Phrase: "Eur."
Processing 00000000.tx.313: J. 

Phrase: "J."
Processing 00000000.tx.314: Endocrinol., 150, 719274.[ISI][Medline] Horsman, M.R. and Overgaard, J. 

Phrase: "Endocrinol.,"

Phrase: "150,"

Phrase: "719274."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Horsman,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Overgaard,"

Phrase: "J."
Processing 00000000.tx.315: (2004) Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Preclinical studies on how to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C1709631:preclinical studies [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1709630:Pre-clinical [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "deal with patient intolerance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030705:*^patient [Patient or Disabled Group]
   770   C0231199:Intolerance [Organism Function]
   770   C1744706:intolerance [Intellectual Product]
   770   C2355652:Intolerance [Organism Attribute]

Phrase: "to nicotinamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028027:Nicotinamide [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "carbogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054692:carbogen [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.316: Radiother. 

Phrase: "Radiother."
Processing 00000000.tx.317: Oncol., 70, 301309.[CrossRef][ISI][Medline] Vila, M. and Przedborski, S. 

Phrase: "Oncol.,"

Phrase: "70,"

Phrase: "301309."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vila,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061396:Vila [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Przedborski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.318: (2003) Targeting programmed cell death in neurodegenerative diseases. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "programmed cell death in neurodegenerative diseases."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:Programmed Cell Death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.319: Nat. 

Phrase: "Nat."
Processing 00000000.tx.320: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.321: Neurosci., 4, 365375.[CrossRef][ISI][Medline] Yang, M.Y., Armstrong, J.D., Vilinsky, I., Strausfeld, N.J. and Kaiser, K. 

Phrase: "Neurosci.,"

Phrase: "4,"

Phrase: "365375."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "M."

Phrase: "Y.,"

Phrase: "Armstrong,"

Phrase: "J."

Phrase: "D."

Phrase: ","

Phrase: "Vilinsky,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Strausfeld,"

Phrase: "N.J."

Phrase: "and"

Phrase: "Kaiser,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.322: (1995) Subdivision of the Drosophila mushroom bodies by enhancer-trap expression patterns. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Subdivision of the Drosophila mushroom bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1273519:Subdivision [Finding]
   753   C1547539:Subdivision [Idea or Concept]

Phrase: "by enhancer-trap expression patterns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.323: Neuron, 15, 4554.[ISI][Medline] Moses, K. and Rubin, G.M. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "15,"

Phrase: "4554."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moses,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rubin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0252873:rubin's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: (1991) Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Glass"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a site-specific DNA-binding protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0012940:DNA Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0812382:DNA-binding protein [Gene or Genome]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "is"

Phrase: "regulated in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to positional signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "in the developing Drosophila eye."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0015392:Eye [Body Part, Organ, or Organ Component]
   827   C1280202:Eye [Body Part, Organ, or Organ Component]
   771 E C0029144:optic [Occupation or Discipline]
   771 E C0042789:Ocular [Organism Function]
   771 E C1299003:Ocular [Spatial Concept]
   734 E C0014236:Ophthalmia [Disease or Syndrome]
   734 E C0700042:Oculus [Body Location or Region]
Processing 00000000.tx.325: Genes Dev., 5, 583593.[Abstract] Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E. and Zipursky, S.L. 

Phrase: "Genes Dev.,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "583593."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Jackson,"

Phrase: "G.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Salecker,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Dong,"

Phrase: "X.,"

Phrase: "Yao,"

Phrase: "X.,"

Phrase: "Arnheim,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Faber,"

Phrase: "P.W., MacDonald,"

Phrase: "M."

Phrase: "E."

Phrase: "and"

Phrase: "Zipursky,"

Phrase: "S.L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439394:s l [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.326: (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Polyglutamine-expanded human huntingtin transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0282641:Transgenes [Gene or Genome]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "degeneration of Drosophila photoreceptor neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   797   C1998028:Photoreceptor degeneration [Disease or Syndrome]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.327: Neuron, 21, 633642.[ISI][Medline]

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "21,"

Phrase: "633642."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

